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Abstract 
Declining male fertility is one of the neglected concerns of people living with HIV/AIDS in 
spite of a dual outlook of a social and a health dilemma. This issue of infertility is particularly 
relevant as majority of affected individuals are in their reproductive years. This thesis examines 
the impacts of the Fixed Dose Combination (FDC) of Highly Active Antiretroviral Therapy 
(HAART) Tenofovir/ Emtricitabine and Efavirenz (TDF/FTC/EFV) on the male reproductive 
capacity. It also explores the protective potentials of a bioactive flavonoid, Naringenin in 
testicular perturbations. The study was motivated by two major research questions namely: (1) 
what are the impacts of the recently approved first line antiretroviral therapy for adults FDC, 
TDF/FTC/EFV on the testes? (2) What is the role of Naringenin in alleviating testicular 
perturbations induced by HAART? Previous studies point to the negative impacts of the older 
generation of FDC of HAART on the semen quality and histomorphometry of the testes 
following a long-term use. The study addresses both the long-term and short-term use of 
antiretroviral drugs as observed in pre-exposure prophylaxis (PrEP) and post exposure 
prophylaxis (PEP). The research assesses the impacts of the drugs on the reproductive 
capability as well.  
Findings from this study support the argument that the negative effects of the drugs were 
consequent upon both the short-term and long-term use. To illustrate this hypothesis, the study 
was conducted in two distinct phases. The first phase which lasted a total of 28 days considered 
the duration of PEP or PrEP. The second phase which lasted a total of ten weeks captured all 
the stages of spermatogenesis in rats. In this phase male Sprague Dawley rats were exposed to 
fertile females after the treatments. The study thus advances an understanding of the 
mechanism of HAART-induced testicular injury. A therapeutic dose of TDF/FTC/EFV 
adjusted for animal weight was aministered on a total of 48 animals randomly divided into 6 
equal groups each with a different treatment as follows; Group A: Control (Distilled water); 
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Group B: HAART (TDF/FTC/EFV), Group C: Naringenin, 40 mg/kg; Group D: Naringenin, 
80 mg/kg; Group E:  HAART + Naringenin, 40 mg/kg; Group F: HAART+ Naringenin, 80 
mg/kg. At the end of each phase, harvested testes were subjected to histomorphometry and 
ultrastructural analysis. The caudal epididymis was assessed for semen parameters and sperm 
mitochondrial DNA (mtDNA) fragmentation. Biochemical parameters such as serum levels of 
reproductive hormones (Luteinizing hormone and Testosterone) and intratesticular antioxidant 
enzyme activities were assayed. Contrary to prior beliefs, this research reveals that the 
immediate effects following short-term use of HAART are far more deleterious. This finding 
is consequent upon the significant drop in the sperm count (p˂0.001) and sperms with normal 
morphology (p˂0.001) compared to (p˂0.01) in the long-term. Histomorphometric analysis 
also revealed a significantly shrunken seminiferous tubule following a short-term use. These 
outcomes were associated with an increase in the mtDNA fragmentation in group B when 
compared to control (p˂0.05). Naringenin reversed abnormalities in groups E and F, displaying 
better semen parameters in both count and motility. Serum levels of testosterone were altered 
in both phases. The overall effects of all these changes were observed in the pregnancy rate 
which reduced in group B when compared to all the other groups. 
This study established that HAART has deleterious effects on the testicular microanatomy and 
function. These effects may impact on steroidogenesis and ultimately spermatogenesis. It 
consequently impairs fertility while Naringenin promises to be a potential complimentary 
adjuvant especially in the short term therapies.  
Keywords: HAART, semen parameters, reproductive hormones, testicular ultrastructure, 3 
beta hydroxysteroid dehydrogenase 
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Isifingqo (Isizulu Abstract)  
Le ngqungquthela ikhanyisa ngemithelela ye-Fixed Dose Combination (FDC) ye-Highly Active 
Antiretroviral Therapy (HAART) Tenofovir / Emtricitabine ne-Efavirenz (TDF / FTC / EFV) 
emandleni okuzala abesilisa futhi iphinde ihlole amandla okuvikela we-flavonoid ephilayo, I-
Naringenin ku-perturbations ye-testicular. Ucwaningo lwalukhuthazwa imibuzo emibili 
yocwaningo; (1) yiziphi impembezo zokwelashwa kwe-antiretroviral emidlalweni yakamuva 
eyamukelwa yilabo abadala abadala i-FDC, i-TDF / FTC / EFV kuma-testes? (2) Iyini indima 
ye-Naringenin, i-antioxidant enamandla ekunciphiseni ukuphazamiseka kwe-testicular 
okubangelwa i-HAART? Ucwaningo oluphambili lubonisa imiphumela emibi yesizukulwane 
esidala se-FDC ye-HAART emkhakheni wezinja kanye ne-histomorphometry yezivivinyo 
ezilandela ukusetshenziswa kwesikhathi eside. Ucwaningo lubhekisela kokubili 
ukusetshenziswa kwesikhathi eside nesikhathi esifushane semishanguzo ye-antiretroviral 
njengoba kwenzeka ngaphambi kokushiswa kwe-prophylaxis (PrEP) nokuthunyelwa kwe-post 
exposure prophylaxis Ucwaningo aluhlolisi kuphela impembelelo kwi-histomorphometry 
kanye nekhwalithi yesilisa kepha futhi nangokwazi ukuzala. 
Siphikisa ukuthi imiphumela emibi ilandelwa kokubili ukusetshenziswa kwesikhathi esifushane 
nesikhathi eside. Ukufanekisa lesi sizathu, isifundo senziwa ngezigaba ezimbili ezihlukene. 
Isigaba sokuqala sicubungula ubude be-PEP noma i-PrEP futhi bugcine izinsuku ezingu-28. 
Isigaba sesibili sagcina amasonto ayishumi ukuze athathe zonke izigaba ze-spermatogenesis 
kuma rats. Kulesi sigaba sokuhlolwa, izibonelo zezilwane, amantombazane amadala 
aseSprague Dawley abuye avulekele kwabesifazane abakhulayo abalandela ukwelashwa. 
Ngakho-ke isifundo sithuthukisa ukuqonda kwethu indlela yokulimala kwe-HACT-induced 
testicular. Sasebenzisa umthamo wokwelashwa we-TDF / FTC / EFV olungiselelwe isisindo 
sezilwane esilinganisweni sezilwane ezingu-48 ngezikhathi ezithile ezihlukaniswe 
ngamaqembu alinganayo angu-6 ngamunye onokwelashwa okuhlukile kanje; Iqembu A: 
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Ukulawula (Amanzi alayishiwe); Iqembu B: I-HAART (TDF / FTC / EFV), Iqembu C: I-
Naringenin, 40 mg / kg; Iqembu D: Naringenin, 80 mg / kg; Iqembu E: HAART + Naringenin, 
40 mg / kg; Iqembu F: HAART + Naringenin, 80 mg / kg. Ekupheleni kwesigaba ngasinye 
sesilingo, izivivinyo zavuna futhi zahlushwa i-histomorphometry kanye nokuhlaziywa 
kwezingqalasizinda kulandelwa izifundo zesimo sokuhlola ukuvunguza kwemifino kanye 
nemithi ephelele ye-epithelium yegciwane, i-lumen ne-intersitium. I-epididymis e-caudal 
yahlolwa nge-paramen parameters kanye nokwahlukana kwe-DNA (i-mtDNA) ye-sperm. 
Imingcele ye-biochemical efana nama-serum ama-hormone wokuzala (i-Luteinizing hormone 
ne-Testosterone) nomsebenzi wokuvikela i-antioxidant enzyme. Inkulumo ye-testicular 3-beta 
hydroxysteroid dehydrogenase (3β HSD) inqume ukuhlola izifundo ze-immunohistochemical. 
Okutholakele kwalolu cwaningo oluphambene nezinkolelo zangaphambili kubonisa ukuthi 
imiphumela esheshayo emva kokusebenzisa isikhathi esifushane kwe-HAART yinto ehlukumeza 
kakhulu ukusetshenziswa kwesikhathi eside. Lokhu kuboniswa ukuhlaselwa okuphawulekayo 
ekubaleni kwesidoda (p˂0.001) kanye nezidakamizwa ezine-morphology evamile (p˂0.001) 
uma kuqhathaniswa ne (p˂0.01) esikhathini eside. Ukuhlaziywa kwe-Histomorphometric 
kwabuye kubonisa ukuthi i-tubul ne-shrunken isetshenziswe kakhulu ngokulandela isikhathi 
esifushane. Lokhu kwahlobaniswa nokwanda kwendlela yokuhlukaniswa kwe-mtDNA 
nokwanda kwamademoni e-group B uma kuqhathaniswa nokulawula (p˂0.05). Ucwaningo 
lubonisa indima yokuvikela yeNaringenin. Lokhu kwakuvezwe ngokwengeziwe esifundweni 
esifushane. Ukungahleleki kwemvelo kwaguqulwa emaqenjini E no-F abonisa imingcele ye-
semen engcono esikhathini esifushane kunesikhathi eside. Ngokuqondene nokubalwa 
kwesidoda kwakukhona ukuthuthukiswa kwezigaba ezimbili ngokuhlanganiswa kwe-HAART 
ne-Naringenin kodwa ukubaluleka kwaqoshwa kuphela esikhathini esifushane (p˂0.01). 
Kodwa i-motility yayithuthukisiwe kangcono ngokuhamba kwesikhathi (p <0.001). Izinga le-
serum testosterone lashintshwa kuzo zombili izigaba. Inkulumo ye-3β HSD yancishiswa 
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ngokusetshenziswa kwe-HART kodwa uNaringenin wakwazi ukubuyisela inkulumo kuye eduze 
evamile. Imiphumela yonke yalezi zinguquko yabonakala ngesikhathi sokukhulelwa 
okwehliswa eqenjini B uma kuqhathaniswa nawo wonke amanye amaqembu. 
Lolu cwaningo luqinisekisa ukuthi ukwelashwa kwe-antiretroviral esebenzayo kunemiphumela 
emibi kakhulu kwi-microanatomy ye-testicular, kanye nomsebenzi. Lezi zingaphazamisa i-
steroidogenesis futhi ekugcineni i-spermatogenesis, ngaleyo ndlela iphazamisa ukuzala kodwa 
uNaringenin uthembisa ukuba yi-adjuvant engase ibe yinkimbinkimbi ikakhulukazi 
emitholampilo
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1. CHAPTER ONE 
INTRODUCTION 
1.0. Background 
The testis is the cardinal organ of reproduction and endocrinal functions in males. An 
optimised reproductive functioning in males is dependent on an intact testicular 
microanatomy. However, it is highly susceptible to damage due to its highly proliferative 
nature (Shaha et al., 2010). Mammalian spermatogenesis is complex because the  process that 
allows minimal deviations from the normal homeostatic milieu of structures involved. The 
testes are exposed to many environmental toxins that threaten the precise ambience required 
for its functions (Tomova and Carroll, 2018). These include radiations, chemicals, diet, 
infections, and drugs (Hao et al., 2016, Ma et al., 2018, Kong et al., 2014, Li et al., 2016, 
Marettová et al., 2015, Awodele et al., 2018). Popular explanations for these injuries are an 
alteration in the microanatomy of the testes ranging from changes in vascular endothelial 
cells and smooth muscle cells, atrophy of the seminiferous tubules, cytoplasmic 
reorganisation and disruption of Sertoli-Sertoli tight junctions (Marettová et al., 2015). Other 
hypotheses regarding testicular insult include hormonal perturbations (Wunder et al., 2008, 
Ma et al., 2007) and free radical injury (Anim et al., 2005, Ma et al., 2018). Despite the 
extensive research on male factor infertility (MFI), many cases are still classified as 
idiopathic which indicates that the exact mechanism of injury is yet to be deciphered.   
Many of the identified toxic agents, particularly drugs, are indispensable due to the lack of 
alternatives. Antiretroviral (ARV) drugs are a good example of this. The drugs have 
succeeded in promoting the health and well-being of people living with Human Immune 
Deficiency Virus (HIV)/ Acquired Immunodeficiency Syndrome (AIDS) (PLWHA) 
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(Nakagawa et al., 2012, WHO, 2016). However, they have had to live with the attendant side 
effects of these drugs ranging from minor dermatological to life-threatening anaphylactic 
reactions. An impairment of male sexual and reproductive performance has been identified 
but neglected. 
Similar to other medical conditions with unknown aetiology, phytonutrients are being 
considered to possess beneficial potentials in restoring testicular functions. A major challenge 
contributing to the paucity of data in this regard is the ethical dilemma researchers face in 
obtaining testicular samples from patients (Ramstein et al., 2017). Fortunately, in spite of the 
interspecies variations, the rodent testis has been found to be similar to that of humans in 
some ways making it a good model for testicular studies (Working, 1988). 
1.1. Anatomy and Physiology of Reproduction in Males 
The male reproductive system comprise of several structures in reproductive, nervous and 
endocrine systems simply termed the hypothalamic-pituitary-testis axis. Production of the 
male reproductive gamete, which is the functional unit of the male reproductive system, takes 
place within the testes and it lasts approximately 3 months. This process is preceded by 
hormonal interactions in the pituitary and hypothalamus. The hormones travel through the 
bloodstream to influence activities within the gonads. 
 Anatomy of the rat testis 
The testes in rats are paired almond-shaped organs located in the pelvis underneath the hind 
limbs. They are particularly larger when compared to the body size of the rats. This fact is 
attributed to the mating habits that are more polygamous (Kenagy and Trombulak, 1986) and 
to the high copulatory frequency and sperm production (Kenagy and Trombulak, 1986, 
Gomendio and Roldan, 1991). The testes are contained in two separate membranes called 
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scrotal sacs. In a young rat, they descend between the ages of 4-6 weeks.  Throughout the 
rat's life, the testes are able to move up into the rat's abdominal cavity because it has an open 
inguinal canal. Spermatogenesis occurs in the epithelial lining of the seminiferous tubes 
found within the testes. Further description of the rat testis is similar to that of humans as 
described below in figure 1. 
 
 
Figure 1: The Reproductive Structures in Rats (Jones, 2018). 
  
 Gross anatomy of the human testis 
The testis is the male gland known to be important for both reproductive (exocrine) and 
endocrine functions. Initially, it begins as an undifferentiated gonad in the retroperitoneal 
area. As the foetus develops, the functioning testis produces the male hormone testosterone 
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to allow development of male genitalia. Within the last 3 months of gestation, the testis must 
course its way down from its original retroperitoneal position to its final destination in the 
scrotum. During its journey, it must pass through the peritoneum, abdominal wall enroute the 
inguinal canal, and then into the scrotal pouch. 
The testis is a paired, ovoid male reproductive organ that sits in the scrotum. It is separated 
from each other by a scrotal septum. Described as being shaped and sized like a large olive 
or small plum, the average volume of the adult testis is approximately 25ml. Typically, it 
measures 3.5-5 cm in length, 2.5-3 cm in both width and 3 cm in depth (anteroposterior 
diameter).   
The testis sits obliquely with its long axis mostly vertical with a slight anterior and lateral 
slant to the superior pole. Superiorly, it is suspended by the spermatic cord, with the left testis 
often sitting lower than the right testis. Inferiorly, the testis is anchored to the scrotum by the 
scrotal ligament, a remnant of the gubernaculum. The tunica vaginalis testis (a remnant of the 
processus vaginalis) envelopes the testis in a double layer, except at the superior and posterior 
borders, where the spermatic cord and epididymis attach to the testes.  
The visceral layer of the tunica vaginalis testis is closely applied to the testis, epididymis, and 
ductus deferens. On the posterolateral surface of the testis, the layer invests a slit-like recess 
between the body of the epididymis and the testis that is called the sinus of epididymis (Moore 
K, 2006).   
The parietal layer of tunica vaginalis which is adjacent to the internal spermatic fascia, is 
more extensive. It extends superiorly into the distal part of the spermatic cord. Deep to the 
tunica vaginalis, the tunica albuginea is a tough fibrous outer covering of the testis. On the 
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posterior surface, it is reflected inwardly to form an incomplete vertical septum called the 
mediastinum testis. 
The mediastinum testis extends from the superior portion to near the inferior area of the gland. 
It narrows in width as it travels inferiorly. Anteriorly and laterally, numerous imperfect septa 
are given off, which radiate to the glands surface and are attached to the tunica albuginea. 
This structure divides the interior of the testis into numerous, cone-shaped spaces that have a 
wide base at the gland’s surface and became narrow as they converge to the mediastinum. In 
the spaces, the numerous lobules of glandular structures (the minute but long and highly 
coiled seminiferous tubules) are housed. The mediastinum supports the ducts and vessels as 
they pass to and from the glandular substance. The seminiferous tubules are lined with germ 
cells that produce sperm and nutrient fluid. These tubules empty their contents into a network 
of anastomosing ducts, which ultimately empties into the epididymis. 
The epididymis is a comma-shaped, elongated structure composed of a single, fine tubular 
structure estimated up to 6 meters (approximately 20 feet) in length. This tube is highly 
convoluted and tightly compressed (average size of approximately 5 cm) to the point of 
appearing solid. Located at the posterior border of the testis, it is composed of three parts, 
namely: the head (caput), body (corpora), and tail (cauda). The epididymal head overhangs 
the upper pole of the testis. It receives the seminal fluid from the ducts of the testis (which 
pierce the upper portion of the mediastinum). It then allows the passage of the sperm into the 
distal portion of the epididymis. Because  of its length, the epididymal duct allows space for 
storage and maturation of sperm. Progressively tapering in width, the narrow tail continues 
as the ductus deferens (Daniel, 2016). 
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 The blood supply to both testes is primarily from the testicular arteries, which arise from the 
anterolateral aspect of the abdominal aorta just inferior to the renal arteries. They travel 
retroperitoneally, cross over the ureters and the inferior parts of the external iliac arteries and 
pass through the deep inguinal ring into the inguinal canal. It then becomes one of the 
components of the spermatic cord. The testicular artery enters the testis through the posterior 
midportion. The testicular artery or one of its branches anastomoses with the artery of the 
ductus deferens. 
Venous drainage from the testis and epididymis form a network of 8-12 veins, called the 
pampiniform venous plexus, lying anterior to the ductus deferens. It surrounds the testicular 
artery in the spermatic cord. The veins converge superiorly forming a testicular vein, after 
passing through the deep inguinal ring. The right testicular vein enters the inferior vena cava, 
while the left testicular vein drains into the left renal vein. Lymphatic drainage of the testis 
follows the testicular vessels (in the spermatic cord) to the right and left lumbar (caval/ aortic) 
and preaortic lymph nodes at the second lumbar level. 
Autonomic innervations of the testis arise as the testicular plexus of nerves on the testicular 
artery, which contains vagal parasympathetic and visceral afferent fibres and sympathetic 
fibres from the T7 segment of the spinal cord. 
  
 Microscopic Anatomy of the Testis 
The testis is composed of lobules of glandular tubules. These tubules are highly convoluted 
structures held together by loose connective tissue with interspersed groups of “interstitial 
cells,” which contain Leydig cells. The individual tubule consists of a basement membrane 
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formed by laminated connective tissue with numerous elastic fibres. There exists flattened 
cells between the layers and covered by an external layer of flattened epithelioid cells. Within 
the basement membrane are epithelial cells arranged in several irregular layers but may be 
separated into germ cells at the periphery and varihumanous cells of spermatogenesis up to 
mature sperm cells as they advance toward the lumen. Also, interspersed in the layer are 
Sertoli cells, which project inward from the basement to the lumen and provide support to 
the developing sperm cells. 
Testicular histology magnified 500 times. Leydig cells reside in the interstitium. 
Spermatogonia and Sertoli cells lie on the basement membrane of the seminiferous tubules. 
Germ cells interdigitate with the Sertoli cells and undergo ordered maturation, migrating 
towards the lumen as they mature. In the apices of the lobules, the tubules are less convoluted. 
They converge into 20-30 larger, straight ducts (tubuli recti). These ducts merge into 
anastomosing tubes in the fibrous stroma, lined with flattened epithelium (rete testis). The 
tubes terminate into approximately 15 ducts that are initially straight in their course.  
After piercing the tunica albuginea at the superior mediastinum, the tubes enlarge and become 
increasingly convoluted. These convolutions are held together by fine areolar tissue and 
bands of fibrous tissue. They form a series of conical masses, the conic vasculosi. The series 
forms the head of the epididymis. The ducts are thicker and lined by ciliated columnar 
epithelium. Below this epithelium is muscular tissue arranged in a mostly circular fashion. 
As the tail of the epididymis merges with the ductus deferens, the microscopic anatomy 
demonstrates a thickened duct with an increased muscular material, increased in diameter, 
and still lined with ciliated columnar epithelium. 
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Figure 2(a): Cross section of the Haematoxylin and Eosin stained rat testis showing the 
microanatomy. S represents seminiferous tubules and I represents the interstitium (Source: 
http://www.columbia.edu/cu/biology/courses/w2501 accessed 08/07/2018) 
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Figure 2(b): Sagittal section of the Haematoxylin and Eosin stained rat testis showing the 
microanatomy (Source: 
www.embryology.med.unsw.edu.au/embryology/index.php?title=file:Testis_histology.jpg&mobilea
ction=toggle_view_mobile accessed 08/07/2018) 
 Comparative testicular histology in man and rodent   
The spermatogenic cycles of man and animals have several similar characteristics with every 
stage being precise in timing, and maturity (Clermont, 1972). There are about five to six 
generations of germ in any given area of the germinal epithelium with the seminiferous 
tubule. These cell populations form associations of definite and fixed configuration (Leblond 
and Clermont, 1952). During any stage of the cellular maturation in the seminiferous 
epithelium, one or two generations of spermatids would be allied with one or two cohorts of 
spermatocytes and spermatogonia. Each of this cell association cytologically forms a stage 
of spermatogenesis. It ranges from specie to specie. There are 6 stages in humans while the 
29 
 
rats have 14 (Leblond and Clermont, 1952, Heller, 1964). The orderly arrangement of the 
spermatogonic series makes up the cycle of the germinal epithelium that appears sequentially 
over time in the same area of the seminiferous epithelium. The duration of time for a cycle 
corresponds to the period from the disappearance of one particular stage to its reappearance 
in a given area of the seminiferous tubule which ranges from 8.6 days in the mouse to 16 days 
in humans. The length of time for the spermatogonic process to be completed, in other words 
for a given stem cell to produce mature sperm cell corresponds to the length of approximately 
4 to 4.5 cycles in laboratory animals and humans (ranging from 35 days in the mouse to 74 
days in humans).  
A cross-section of a mammalian testis displays numerous cross-sections of the seminiferous 
tubules (Figure 2).  It has been revealed that “In most mammals, the stages of spermatogenesis 
appear not only sequentially in time, but also sequentially in space (along the length of the 
seminiferous tubule). This wave of the seminiferous epithelium has been described for 
numerous model species” (Perey et al., 1961). The unpredicted consequence of this wave is 
that each seminiferous tubule has only a single spermatogenic stage when viewed in cross-
section. This makes it easier to quantify the toxic effects of gonadotoxic agents in the animal 
testis. However, this is not the case in humans as the arrangement of germ cells in the 
seminiferous epithelium are not as orderly when the tubule is viewed in whole mount. 
Specific cellular associations appear in irregular zones throughout the seminiferous 
epithelium. Also there are numerous heterogeneous stages made up of unexpected presence 
or absence of germ cells in typical cell associations (Heller, 1964). Consequently, a cross-
section through a tubule reveal an array of cells of diverse stages. Later, some researchers 
who utilized morphological and morphometric methods to study human spermatogenesis 
(Schulze and Rehder, 1984) reported that increasingly mature spermatocyte populations are 
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arranged on helices that are contracted conically towards the lumen of the seminiferous 
tubule. They emphasised that this arrangement could be a natural outcome of the markedly 
lower rate of spermatogonial division in humans in comparison with other mammals.  They, 
therefore, concluded that "quantitation of toxic effects on spermatogenesis is a much more 
difficult task in humans, and direct comparison to animal models may not always be possible 
or warranted." (Schulze and Rehder, 1984). 
 Determination of spermatocyte and spermatid numbers are alternative methods that have 
been described for the determination of sperm production rates from testicular histology in 
humans (Berndston, 1977, Steinberger and Tjioe, 1968). These methods can also be used to 
assess reproductive toxicity if testicular samples are available. Due to the difficulties in 
obtaining testicular biopsies of humans, assessment of reproductive toxicity is usually limited 
to semen analysis which consists of sperm count, determination of the percentage of 
progressively motile sperms, the percentage of sperms with abnormal morphology and the 
volume as well as the consistency of the semen over a short period. 
 
1.2. Spermatogenesis 
Spermatogenesis is the process of gradual transformation of germ cells into spermatozoa. It 
occurs mainly within the seminiferous tubules of the testes and can be divided into three 
phases, each of which is associated with a different type of germ cell:  
 Proliferative phase: spermatogonia → spermatocytes  
 Meiotic phase: spermatocytes → spermatids  
 Differentiation phase (also known as spermiogenesis): spermatids → spermatozoa  
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Unlike the female production of gametes which occurs entirely before birth and gamete 
maturation occurring in a pulsatile fashion after puberty, males produce gametes continuously 
from puberty all through their reproductive lives and the release of the gametes is constant.   
 
  
Figure 3: Schematic illustration of the stages of spermatogenesis. The direction of the arrow 
indicates the successive stages of spermatogenesis. The green parts of the arrow indicate 
active transcription, the red parts represent point of transcriptional arrest and transcriptional 
cessation. 
The seminiferous tubules are the site of spermatogenesis. The two main cell types within the 
tubules involved in spermatogenesis are the germ cells, which develop into sperms and 
somatic cells known as Sertoli cells, which nurture the germ cells throughout the development 
process. As the germ cells progress through the various stages of development, they move 
slowly from the basement membrane of the tubules through the tight junctions between the 
Sertoli cells into the tubular lumen.  
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 Stages of spermatogenesis  
1.2.1.1. Proliferation phase 
Stem or A spermatogonia located in the basal region of the tubular epithelium undergo 
mitosis. The progeny of these divisions maintain their own numbers as well as giving rise to 
several interconnected B spermatogonia (the number of these arising from a single A 
spermatogonia is species dependent). B spermatogonia divide to give rise to primary (1o) 
spermatocytes. All descendants of a B spermatogonium remain connected by cytoplasmic 
bridges, forming a syncytium - like cell clone which undergoes synchronous development. 
  
1.2.1.2. Meiotic phase  
Each 1o spermatocyte divides to give rise to two short-lived secondary (2o) spermatocytes, 
which in turn give rise to two spermatids each. The spermatids contain a haploid number of 
chromosomes (half the number of a somatic cell). Primary spermatocytes are the largest cells 
in the spermatogenic series and are located approximately midway within the seminiferous 
epithelium. The process of meiosis occurs over a long period, with prophase of the first 
meiotic division taking up to three weeks (Hess 1999; Cunningham, 2007). 
 
1.2.1.3. Differentiation phase  
The differentiation phase is also known as spermiogenesis. During this phase spermatids 
undergo transformation into spermatozoa. Many changes occur within the cells, the three 
major changes are:  
i) formation of the acrosome that covers the cranial part of the head. The acrosome will 
contain hydrolytic enzymes to allow fusion of sperm and egg for fertilization. 
33 
 
ii) condensation of nuclear chromatin in the head to form a dark-staining structure  
iii) growth of the tail opposite the acrosome, and loss of excess cytoplasmic material which 
is shed as a residual body. The body is phagocytosed by the Sertoli cells. The morphological 
changes occurring during this process can be seen when sections of different seminiferous 
tubules are examined.   
 
 Spermatogenic cycle and wave 
A spermatogenic cycle represents the time required for one cell to go through all the stages 
of spermatogenesis. Since the spermatogenic cycle lasts a certain length of time and each step 
occupies a specified duration, a finite number of cellular association results. This means that 
specific groupings of cells in different steps of spermatogenesis will coexist. There usually 
exist an overlapping of different generations presents within the germinal epithelium at a 
particular point in time. The series of changes between two successive appearances of the 
same cellular associations make up one cycle of the seminiferous epithelium. One cellular 
association is a stage of the seminiferous cycle. Stages of the cycle may be recognized by the 
appearance of the acrosome, meiotic divisions, and the shape of the spermatid nucleus, the 
release of the spermatozoa or a combination of all characteristics (Clermont, 1972). 
There exist an organized progression of the different stages of spermatogenesis along the 
tubule. This phenomenon is known as the spermatogenic wave. It is in actual fact the 
changing cellular associations in space instead of time. This progression of stages 
makes certain the continual production of spermatozoa at any specific time (Hogarth and 
Griswold, 2010). The cycle is useful in quantitating the effects of drugs, hormones, nutritional 
factors, etc., on the different steps of spermatogenesis.  There are specie differences in the 
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number of cellular associations in a cycle of the epithelium depending on the number of 
spermatogonial divisions in that specie and the number of distinguishable stages of spermatid 
development in that specie (Perey et al., 1961). 
 
 
Figure 4: Depiction of the spermatogenic wave, the organized progression of the different 
stages of spermatogenesis along the tubule. The point of meiotic initiation (red arrows) moves 
in the direction of the black arrows leading to continual and asynchronus release of 
spematozoa (Hogarth and Griswold, 2010). 
  
 Interspecies spermatogenetic differences  
The human male is of relatively low fertility compared to most animal species. An estimated 
15 to 20% of all American couples are infertile (Gray, 2000), less than one-third of all 
conceptions result in a live birth and some 20% to 30% of all developmental defects have 
genetic origins (Swartz MH, 2006). Between 10 and 20 chemicals or drugs have been directly 
demonstrated to adversely affect human male reproduction (Gray, 2000). Substantial 
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information concerning reproductive toxicants has been collected using animal models. Thus, 
the scientific process for the evaluation of human reproductive risk from drug and chemicals 
includes extrapolation from data obtained using these models.   
Spermatogenesis in rats occurs in the seminiferous tubules, consisting of approximately 10 -
20 in each rat testis. During spermatogenesis, the primitive, diploid, stem cell spermatogonia 
give rise to highly differentiated, haploid spermatozoa. The process involves several mitotic 
divisions of the spermatogonia, which eventually results in the production of the 
spermatocyte.  The spermatocyte is the cell which undertakes the course of meiosis beginning 
with duplication of its DNA during preleptotene, pairing and condensing of the chromosomes 
during pachytene and finally culminating in two reductive divisions to produce the haploid 
spermatid. The spermatid starts as a round cell then rapidly undergoes a series of complex 
morphological changes. The nuclear DNA becomes highly condensed and elongated into a 
head region which is covered by a glycoprotein acrosome coat while the cytoplasm develops 
into a whip-like tail flagellum and tightly-packed mitochondria.  The successive 
morphological steps in the differentiation of the spermatid (19 steps of spermiogenesis) 
provide the basis for the identification of the stages of the spermatogenic cycle in the rat.  
In a cross-section of a seminiferous tubule, the germ cells are arranged in discrete layers. 
Spermatogonia lie on the basal lamina, spermatocytes are arranged above them and then one 
or two layers of spermatids above them. In any given normal tubule, four generations of cells 
develop concurrently and in precise synchrony with each other.  As each generation develops, 
it moves up through the epithelium, continuously supported by Sertoli cells until the matured 
sperms are released into the tubular lumen in a process called spermiation.  The synchrony 
of the development between the 4 cells is such that each successive stage of development of 
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the spermatogonium is found with its characteristic spermatocyte and spermatids. The 
synchronous development of the 4 in the repetitive appearance of specific cell associations 
are referred to as stages of the spermatogenic cycle. Fourteen of such cell associations occur 
in the rat and are referred to as stages I-XIV of the spermatogenic cycle. The main known 
effects of testosterone that supports spermatogenesis are to stimulate seminiferous tubule 
fluid production, regulate the release of the mature spermatids from the Sertoli cell and to 
support the pachytene spermatocytes and later germ cell types through stage VII of the 
spermatogenic cycle. This spermatogenic support appears to be mediated by the secretion of 
several specific proteins from the Sertoli, peritubular and germ cells whose secretion is 
dependent on testosterone as well as a full complement of germ cells. Selective depletion of 
any of the different populations of cells from these stages will differentially alter the secretion 
of each of the androgen-regulated proteins.   
 
 The hypothalamus, pituitary gland and hormonal control of spermatogenesis 
The hypothalamus is a small almond-sized region of the brain located directly above the 
brainstem. It is a collection of nuclei that performs a variety of functions mainly homeostatic 
and hormonal. It controls body temperature, blood pressure, and caloric intake as well as the 
expenditure at a fairly constant level. One of the ways in which the hypothalamus can restore 
homeostasis and influence behaviour is through the control of hormone release from the 
pituitary gland. It does this by releasing gonadotropin-releasing hormone (GnRH). The 
hypothalamus is anatomically and functionally related to the pituitary gland (hypophysis), a 
bean-sized organ lying within the sella turcica of the sphenoid bone of the skull.  The pituitary 
gland is suspended from it by a stem called the infundibulum, a bridge of capillaries that 
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connects the hypothalamus to the anterior pituitary. It is made up of two lobes- the anterior 
and the posterior. 
 
 
 
 
 
 
 
  
 
 
Figure 5: Schematic representation of the hypothalamic–pituitary–testicular (HPT) axes 
(Kong et al., 2014). 
The posterior stores two hormones produced by the hypothalamus (oxytocin and antidiuretic 
hormone). The anterior is responsible for the secretion of hormones under the influence of 
releasing hormones from the hypothalamus. The hypophyseal portal system allows 
hypothalamic hormones to be transported to the anterior pituitary without first entering the 
systemic circulation. 
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Spermatogenesis is controlled by a complex feedback mechanism involving the 
hypothalamus, anterior pituitary, and testes. Gonadotrophic releasing hormone (GnRH) is 
released by the hypothalamus in a pulsatile manner and travels through portal vessels to the 
anterior pituitary, where it acts as the gonadotrophic cells. These cells respond to the 
stimulation by producing either follicle stimulating hormone (FSH) or luteinizing hormone 
(LH) depending on the pattern of GnRH secretion.  
LH and FSH travel in the bloodstream to the testes, where LH acts on the Leydig cells to 
stimulate conversion of steroids to testosterone and other androgens. This process in turn 
contribute to the stimulation of Sertoli cells. FSH acts on the receptors of Sertoli cells and, in 
combination with testosterone, stimulates many functions, including synthesis and secretion 
of oestrogen, inhibin and many other products, meiosis, spermatocyte maturation and Leydig 
cell function.  Inhibin, testosterone and oestrogen feedback negatively on the anterior 
pituitary and hypothalamus to suppress secretion of gonadotrophic hormones (Figure 2).   
The disruption of the balanced system may cause disorders of reproduction. The lack of 
appropriate cyclical release of GnRH by the hypothalamus leads to loss of normal pulsatile 
LH release by the pituitary gland. This results in impaired testosterone and sperm production 
in men. The cause of disturbed cyclic release of GnRH is unclear, though hyperprolactinemia, 
elevated endorphins, and high levels of GnRH and LH caused an underlying medical 
condition have been implicated.  
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1.3. Fertility issues in males 
Reproduction is the result of an interaction between the structural and functional property of 
an organism. A successful reproduction is thus dependent on the efficiency of the physiology 
of the reproductive system which is also largely determined by a normal anatomy of the 
organism. It, therefore, means that a structural defect in the reproductive system of an 
organism may result in subfertility or infertility when severe. Infertility is "a disease of the 
reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or 
more of regular unprotected sexual intercourse" (Zegers-Hochschild et al., 2009). Male 
infertility, however, refers to a male's inability to cause pregnancy in a fertile female. In men, 
it accounts for 40–50% of infertility (Hirsh, 2003, Brugh and Lipshultz, 2004) and 
approximately 7% of all men are affected (Lotti and Maggi, 2014). A male infertility factor 
is identified in about 50% of these cases and is solely responsible in 20% of couples. Majority 
of male reproductive problems have an underlying anatomic basis. 
 
 Anatomical basis of male infertility  
 For the purpose of this write-up, the causes of male infertility will be categorized as 
pre-testicular, intra-testicular and post-testicular causes. 
1.3.1.1. Pre-testicular causes 
These are a group of rare endocrine conditions in the extra-gonadal system resulting in male 
factor infertility, such as those originating in the hypothalamus, pituitary, or adrenals, and 
have an adverse effect on spermatogenesis (Robertson et al., 1999). It is a less common 
aetiology than other causes of male infertility that result in deficient androgen secretion and 
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subsequently impaired spermatogenesis. It is termed hypogonadotropic hypogonadism, 
secondary or central hypogonadism. There are two main types, 
 Primary hypogonadism hypogonadotropic: this is a genetic disorder that prevents 
onset or completion of puberty. All hormonal levels are diminished, the hormones of 
the pituitary and testicles do not have the required levels of proper testicular function. 
The underlying cause of hypogonadotropic hypogonadism is a failure in the correct 
action of the hypothalamic hormone GnRH. This failure in GnRH activity can either 
be due to the absence of the GnRH releasing neurones inside the hypothalamus due 
to a failure of LHRH cells to migrate into the brain (Schwanzel-Fukuda et al., 1989) 
or the inability of the hypothalamus to release GnRH in the correct pulsatile manner 
to ensure LH and FSH release from the pituitary (Mitchell et al., 2011). A number of 
gene defects have been attributed to this condition (Layman et al., 2013, Valdes-Socin 
et al., 2014, Melmed, 2015). A prevalence rate of 1: 10,000-30,000 males have been 
reported (Chauvel, 1973, Laitinen et al., 2011). 
 Secondary hypogonadotropic hypogonadism, also known as acquired or syndromic 
hypogonadotropic hypogonadism, is commoner than primary hypogonadotropic 
hypogonadism. It is responsible for most cases of the condition. It has  many causes 
ranging from pituitary and hypothalamic tumours, pituitary apoplexy, head trauma, 
ingestion of certain drugs including abusive alcohol or illicit drug intake, 
hemochromatosis, systemic disorders such as chronic illnesses, pituitary/brain 
radiation, exhausting exercise, nutritional deficiencies to obesity (Fraietta et al., 
2013). 
41 
 
Other causes of pre-testicular infertility include coital disorders such as erectile dysfunction 
and ejaculatory maladies. These are difficulties experienced by an individual or a couple 
during any stage of a normal sexual activity, including physical pleasure, desire, preference, 
arousal or orgasm. They are very rare causes of infertility.  Anejaculation, retrograde 
ejaculation and orgasmic dysfunction are examples of conditions that can give rise to coital 
disorders. They are associated with retroperitoneal lymph-node dissection (Dimitropoulos et 
al., 2015), spinal cord injury (Brackett, 1999), bladder neck surgery (Hedlund and Ek, 1985, 
Kochakarn and Lertsithichai, 2003) and multiple sclerosis (Colpi et al., 2004). Anejaculation 
is the complete absence of an antegrade or retrograde ejaculation. It is caused by a failure of 
emission of semen from the seminal vesicles, the prostate, and the ejaculatory ducts into the 
urethra while retrograde ejaculation is the total or sometimes partial absence of an antegrade 
ejaculation because semen passes backwards through the bladder neck into the bladder. 
Anorgasmia is an orgasmic dysfunction characterized by the inability to reach orgasm and 
result in anejaculation (Colpi et al., 2004). 
1.3.1.2. Intra-testicular causes 
The testis is an organ saddled with two main functions- androgen synthesis (steroidogenesis) 
and spermatozoa production spermatogenesis. Perturbations in either or both function for any 
reason can lead to infertility. Intratesticular cause of infertility refers to factors that affect 
normal sperm production by the testicle. The testes produce sperm of low quantity and/or 
poor quality despite adequate hormonal support from the hypothalamus and pituitary gland. 
This can be due either to a disorder of steroidogenesis or spermatogenesis. 
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 Disorders of steroidogenesis 
Hypergonadotropic hypogonadism also known as primary or peripheral/gonadal 
hypogonadism, is a condition which is characterized by hypogonadism due to an impaired 
response of the gonads to the gonadotropins, and in turn a lack of sex steroid (testosterone) 
production and elevated gonadotropin levels. The disorder may be congenital or acquired 
(Katz et al., 2011). It causes dysfunctional testes presenting as oligospermia or azoospermia. 
This is also known as primary testicular failure. 
Congenital causes include:  
i. Chromosomal abnormalities (resulting in gonadal dysgenesis) - Turner's syndrome, 
Klinefelter's syndrome, Swyer's syndrome, XX gonadal dysgenesis, and mosaicism. 
ii. Defects in the enzymes involved in the gonadal biosynthesis of the sex hormones - 
17α-hydroxylase deficiency, 17, 20-lyase deficiency, 17β-hydroxysteroid 
dehydrogenase III deficiency, and lipoid congenital adrenal hyperplasia. 
iii. Gonadotropin resistance (e.g., due to inactivating mutations in the gonadotropin 
receptors) - Leydig cell hypoplasia (or insensitivity to LH) in males, and LH and FSH 
resistance due to mutations in the GNAS gene (termed pseudohypoparathyroidism 
type 1A). 
Acquired causes are due to damage to the testes include vanishing/anorchia, orchitis, trauma, 
surgery, autoimmunity, chemotherapy, radiation, infections, toxins (capable of endocrine 
disruption), and drugs such as antiandrogens, opioids, alcohol (Luzzatto, 2007, Katz et al., 
2011). 
Disorders of spermatogenesis 
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• Germ cell aplasia also known as Sertoli cell-only syndrome, is a rare histologic 
diagnosis whereby the seminiferous tubules are completely devoid of germ cells and are lined 
only with Sertoli cells with minimal or no fibrosis or hyalinization (Matsumoto and Bremner, 
2011). The disorder is characterized by infertility, normal androgenization, normal to 
moderately small testes, azoospermia, normal testosterone and LH levels, and selectively 
elevated FSH levels. The high level of FSH suggests severe seminiferous tubule dysfunction 
(Whorton et al., 1979). Seminal plasma protein TEX101 was proposed for differentiation of 
Sertoli cell-only syndrome from maturation arrest and hypospermatogenesis (Drabovich et 
al., 2013, Korbakis et al., 2017). 
The cause of Sertoli cell-only syndrome is not known, though it is thought to result from the 
congenital absence of germ cells due to a failure of gonocyte migration. A Sertoli cell–only 
histology may be associated with microdeletions in the long arm of the Y chromosome in the 
AZF regions (Kong et al., 2014). Severe germ cell damage and loss occurring with Klinefelter 
syndrome, mumps orchitis, cryptorchidism, ionizing radiation, or alkylating agents may 
result in seminiferous tubules lined only with Sertoli cells. However, in these cases of 
acquired Sertoli cell–only syndrome, there is usually extensive seminiferous tubule sclerosis 
or hyalinization, and the testes are usually smaller. Infertility is irreversible in congenital 
Sertoli cell–only syndrome, but it may be reversible with time in some cases of an acquired 
Sertoli cell-only syndrome (Matsumoto and Bremner, 2016). 
1.3.1.3. Post-testicular causes  
These are conditions that affect the ability of the sperm to travel from the testes where they 
are produced to leave the body in the ejaculate. Examples include:  
• Complications from a hernia repair, 
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• Absent vas deferens,  
• Ejaculatory duct abnormalities 
• Vasectomy  
• Genital tract infection 
• Genetic factors such as the congenital bilateral absence of vas deferens (CBAVD) 
in cystic fibrosis, 
• Retrograde ejaculation,  
• Hypospadias and  
• Erectile dysfunction. 
1.4. Human Immunodeficiency Virus (HIV)/ Acquired Immune Deficiency Syndrome 
(AIDS) 
Human Immunodeficiency Virus Infection and Acquired Immune Deficiency Syndrome 
(HIV/AIDS) is a spectrum of illnesses caused by infection with the Human 
Immunodeficiency Virus through unprotected sex, contaminated blood transfusions, 
hypodermic needles, and from mother to child during pregnancy, delivery, or breastfeeding 
(Rom and Markowitz, 2007). In 2016, an estimated 36.7 million people were living with HIV 
and it led to 1 million deaths (UNAIDS, 2017a). Since the early 1980s when AIDS was 
identified until 2017, the disease has caused an estimated 35 million deaths worldwide 
(UNAIDS, 2016) HIV/AIDS is considered a pandemic that originated from west-central 
Africa during the late 19th or early 20th century (Sharp and Hahn, 2011). AIDS was first 
recognized by the United States Centre for Disease Control and Prevention (CDC) in 1981 
and its cause—HIV infection—was identified in the early part of the decade (Gallo, 2006). 
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HIV/AIDS has impacted greatly on society, as a disease, a source of discrimination as well 
as a huge economic burden both on the individuals and the government (Jain et al., 2018, 
Ismail et al., 2017b, Poudel et al., 2017). The disease has become subject to many 
controversies involving religions, such as the Catholic Church's position not to support 
condom use as prevention (Carey, 2018). It has attracted global medical and political 
attention as well as significant funding since it was discovered (Piot et al., 2015, McKinney 
and Marconi, 2016).  
 HIV/AIDS Pathogenesis 
The disease is characterized by three clinical stages. The initial period following infection 
with the HIV is called acute retroviral syndrome (Kirton, 2010, AIDS Education and Training 
Centers National Coordinating Resource Center (AETC NCRC)", 2013, World Health 
Organization, 2007), The stage is characterized by an influenza-like or a mononucleosis-like 
illness within 2–4 weeks of exposure in many individuals while others have no significant 
symptoms. Symptoms occur in 40–90% of cases and most commonly include fever, large 
tender lymph nodes, throat inflammation, a rash, headache, tiredness, and/or sores of the 
mouth and genitals. Due to their nonspecific character, these symptoms are not often 
recognized as signs of HIV infection. The second stage following the initial symptoms is 
followed by a stage called clinical latency, or chronic HIV (Rom and Markowitz, 2007). 
Without treatment, this second stage can last from about 3 years (Evian, 2007) to an average 
of about eight years) (Elliott et al., 2012). While typically there are few or no symptoms at 
first, near the end of this stage many people experience fever, weight loss, gastrointestinal 
problems and muscle pains. Between 50 and 70% of people also develop persistent 
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generalized lymphadenopathy, characterized by unexplained, non-painful enlargement of 
more than one group of lymph nodes (Tenner-Racz et al., 1988). 
 The last stage is the development of Acquired immunodeficiency syndrome (AIDS) is 
defined in terms of either a CD4+ T cell count below 200 cells per µL or the occurrence of 
specific diseases in association with an HIV infection (Smurzynski et al., 2010). In the 
absence of specific treatment, around half of people infected with HIV develop AIDS within 
ten years. The most common initial conditions that alert to the presence of AIDS are 
pneumocystis pneumonia (40%), cachexia in the form of HIV wasting syndrome (20%), and 
oesophageal candidiasis (World Health Organization, 2007). Other common signs include 
recurrent respiratory tract infections (Smurzynski et al., 2010). Opportunistic infections that 
are normally controlled by the immune system (Holmes et al., 2003) affect almost all organ 
system at this stage of the disease (Chu and Selwyn, 2011). 
  
 Drug Treatment of HIV/AIDS 
Antiretroviral (ARV) drugs are medications for the treatment of infection caused by 
retroviruses, such as HIV. The World Health Organization (WHO) has recommended a 
combination of ARV in the form of antiretroviral therapy (ART) for people starting HIV 
treatment (WHO, 2016). ART involving a combination of three or more ARV drugs for the 
lifelong treatment of persons living with HIV is known as Highly Active Antiretroviral 
Therapy (HAART) (WHO, 2016). 
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1.4.2.1. Highly Active Antiretroviral Therapy (HAART)  
The standard treatment consists of a combination of at least three drugs often HAART that is 
used mainly to suppress HIV replication. These drugs belong to different classes of 
antiretroviral agents that act on different stages of the HIV life-cycle. The advent of HAART 
in the management of HIV witnessed a significant reduction in the morbidity and mortality 
rates (UNAIDS, 2017b, UNAIDS, 2013, Watkins and Treisman, 2015). Significant advances 
in ART have been made since the introduction of zidovudine (AZT) in 1987. The mortality 
among patients with AIDS was nearly halved in the HAART era (Mocroft et al., 2003). (See 
Figure 3).  
Today people living with HIV and AIDS (PLWHAs) have a life expectancy of more than 60 
years and can go about their normal daily activities with little or no fear of stigmatization and 
discrimination. This is shown in Figure 3. As HIV management with ART has become more 
aggressive, survival has improved. Life expectancy with HIV infection is not yet equivalent 
to that in uninfected people. In spite of this, HAART has been accompanied with new 
challenges especially as regards toxicity (Bujan et al., 2007, Semprini et al., 2013, 2015). 
Table 1 shows the different classes of ARV drugs and their side effects.  
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Figure 6: Changes in the survival of PLWHA in the Pre-HAART, Early HAART, and Late 
HAART era  
Source: https://emedicine.medscape.com/article/1533218-overview accessed 19/04/2018 
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Figure 7: Adjusted relative risk of AIDS or death in PLWHA over time (Mocroft et al., 2003). 
 
1.4.2.2. Pharmacologic drug classes of ARDs  
Pharmacologic drug classes of ARDs include: 
 Nucleoside reverse transcriptase inhibitors (NRTIs)  
 Non-nucleoside reverse transcriptase inhibitors (NNRTIs)  
 Protease inhibitors (PIs)  
 Integrase inhibitors (INSTIs) 
 Chemokine receptor antagonists (CCR5 antagonists)  
The use of these agents is tailored to the individual patient and is essentially dictated by their 
ease or complexity of use, side-effect profile, efficacy based on clinical evidence, practice 
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guidelines, and clinician preference. Other factors such as Resistance, adverse effects, 
pregnancy, and coinfection with hepatitis B virus, or hepatitis C virus are also important 
considerations before the choice of drug combination is made. The table 1 summarises the 
Federal Drug Agency (FDA)-Approved antivirals and regimens 
Table 1: Pharmacologic drug classes of ARD  
 Class Examples Side effects 
1 Nucleoside reverse 
transcriptase 
inhibitors (NRTIs)  
 
Abacavir, Stavudine 
didanosine, 
emtricitabine, 
lamivudine, Tenofovir, 
zidovudine 
Peripheral neuropathy, lipoatrophy, 
pancreatitis, hepatitis, lactic acidosis, 
mitochondrial toxicity, nausea, 
vomiting, haematological toxicities 
(Zidovudine) 
2 Non-nucleoside 
reverse 
transcriptase 
inhibitors 
(NNRTIs)  
 
Efavirenz, Etravirine, 
Neirapine, Rilpivirine 
Rash, teratogenicity, enzyme 
induction, fever, nausea, diarrhoea, 
hepatotoxicity. CNS abnormalities 
e.g. somnolence, vivid dreams, 
confusion, visual hallucinations 
(efavirenz) 
3 Protease inhibitors 
(PIs)  
 
Atazanavir, 
Fosamprenavir, 
Darunavir, 
Lipodystrophy, gastrointestinal 
intolerance, hyperglycaemia, lipid 
abnormalities, 
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Indinavir, 
Lopinavir/ritonavir, 
Ritonavir,  
4 Integrase inhibitors 
(INSTIs)  
 
Raltegravir, 
Dolutegravir, 
Elvitegravir 
 
    Diarrhoea, nausea,    fatigue,   
headache,    insomnia, skin reactions   
5 Chemokine receptor 
antagonists (CCR5 
antagonists)  
 
Maraviroc, Enfuvirtide Diarrhoea, nausea, hepatitis, upper 
respiratory tract infection, fatigue, 
dizziness, headache, joint and muscle 
pain 
 
Initial regimens use first-line drugs that have a high efficacy and low side-effect profile. The 
WHO preferred First-line ART for adults should consist of two nucleoside reverse 
transcriptase inhibitors (NRTIs) plus a non-nucleoside reverse transcriptase inhibitor 
(NNRTI) or an integrase inhibitor (INSTI) (WHO, 2016). 
  
 Reproductive toxicities of HAART 
The effects of HIV treatment on several organ systems in the body have been examined by 
many researchers. Adverse effects have been reported with the use of all ARV drugs and are 
among the most common reasons cited for switching or discontinuing therapy and for 
medication non-adherence. These have compromised the benefits of ART. The adverse 
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effects range from those that are associated with minor discomfort to those that are life 
threatening such as insulin resistance, lipodystrophy syndrome, gastrointestinal symptoms 
and bleeding dyscrasias (Schambelan et al., 2002, Hagmann et al., 2003). As a consequence, 
the side effects of ARVs on fertility especially in a growing population have become a 
significant cause for concern. 
Testicular toxicity has been a major albatross of HAART especially with the Nucleoside 
reverse transcriptase inhibitors (NRTIs) as it affects and limits the fertility of young men 
(Lewis W, 2003, van Leeuwen E, 2008, Azu et al., 2014). Tenofovir has been reported to 
cause renal proximal tubular ultrastructural defects and depleted mtDNA in that specialized 
tissue (Kohler et al., 2009, White et al., 2001), suggested that the proportion of patients with 
mitochondrial DNA (mtDNA) deletions was significantly greater in those patients who had 
taken HAART for more than 12 months compared with those who had taken HAART for less 
than 12 months. In addition, there are some case base reports of Acute Liver Toxicity due to 
Efavirenz/Emtricitabine/Tenofovir combination (Patil et al., 2015, Echenique and Rich, 
2013, Sperm morphology has been regarded as the hallmark of successful fertilization 
(Franken et al., 2000). Spermatogenesis and androgen production are under the hormonal 
regulation from the hypothalamus, anterior pituitary, and the testes. Some ARV has been 
identified as disruptors of gonadal function by causing lower testosterone levels, 
oligospermia, azoospermia and gynaecomastia (Sellmeyer and Grunfeld, 1996) thereby 
leading to reproductive failures. 
The seminiferous tubules have been shown to be particularly sensitive to the effects of 
HAART thereby rendering patients oligospermic and even azoospermic (Wallace et al., 
2005). Several studies have discovered that HAART is particularly injurious to the testis as 
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autopsy studies done on individuals who died of Acquired Immunodeficiency Syndrome 
(AIDS) revealed testicular histomorphologic abnormalities reduced spermatogenesis as well 
as testicular atrophy in more than 95% of cases (Da Silva M, 1990). In 2011, Nicopoullos 
and his colleagues postulated that HAART significantly decreases total sperm count, 
progressive motility, and increases the number of abnormal forms (Nicopoullos et al., 2011). 
The spermatozoa have been shown to contain numerous mitochondria necessary to provide 
the energy required for progressive motility (van Leeuwen E, 2008). Some authors have 
hinged the decrease in progressive sperm motility on the nexus between HAART induced 
toxicity and mitochondrial damage (Soriano et al., 2008, Kohler et al., 2009, Patil et al., 2015) 
links hepatotoxicity with mitochondrial DNA damage also stating that NRTIs inhibit the 
mitochondrial polymerase γ (poly-γ hypothesis). In addition, HAART induced toxicity has 
been reported to cause deleterious histopathological changes in the testes causing tubular 
atrophy with altered morphometric indices (Azu et al., 2014). This brings to the fore a 
looming challenge of infertility among men on HAART which may militate against their 
ability to father their own biological children. The above mentioned toxicities associated with 
the different class of antiretroviral drugs have been further summarised in table 2. 
The mechanism by which HAART induces organ toxicity is due to a cascade of events 
involving the oxidant-antioxidant pathway (Azu et al., 2014, Babatunde et al., 2015). Earlier 
studies have reported that increased activities of reactive oxygen species (ROS) overwhelm 
tissue`s total antioxidant status leading to oxidative stress (Aitken, 2008). Oxidative stress 
leads to increased lipid peroxidation indicated by malondialdehyde (MDA) markers, 
deleterious to the unsaturated fatty acid-rich membrane of the spermatozoon (Oremosu and 
Akang, 2015). 
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Consequent on the fact that HIV is most prevalent among individuals of reproductive age 
with about one-third of them desiring to have their own biological children, consideration of 
reproductive desires has become clinically important in the management of PLWHAs 
(Kushnir and Lewis, 2011). This agrees with the findings of a study in Tanzania among HIV 
positive men and women. The study reported a significant number of HIV positive men 
mostly those who had never had children desired to have their own biological children 
(Mmbaga et al., 2013). 
Currently, the most specialized means of managing infertility is through assisted reproduction 
techniques especially in vitro fertilization (IVF) (Agarwal and Allamaneni, 2005, Buzadzic 
et al., 2015, Practice Committee of the American Society for Reproductive Medicine, 2006). 
The financial implication of using this method is alarming and beyond the reach of most 
middle class citizens (Okonofua and Obi, 2009, Tjon-Kon-Fat et al., 2015). More so, IVF is 
vitiated by the low success rates in most fertility centres (Crawford et al., 2016, Smith et al., 
2015), necessitating the quest for a new therapeutic approach for improvement in fertilization. 
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Table 2: Summary of testicular effects of Highly Active Antiretroviral Therapy (HAART) (adapted from Azu et al., 2012; Azu, 2012) 
Treatment Effects Experimental 
Type 
Duration Reference 
NNRTI: nevirapine Degeneration of seminiferous tubules, necrosis 
of spermatids, and defoliation of spermatocytes, 
reduction in sperm motility and viability 
Animal 4 weeks (Adaramoye et al., 2012) 
Zidolam (AZT+3TC) Reduced sperm motility and count and viability, 
reduced testosterone 
Animal 21 days (Osonuga et al., 2010) 
Zidovudine + lamivudine Increase in free testosterone Human prospective 
randomized trial 
7 days (Dubé et al., 2007) 
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HAART Impairment in testosterone levels Human, cross‐
sectional study 
6 months (Rochira et al., 2015, 
Rochira et al., 2011) 
HAART Levels of testosterone, 17‐estradiol, 17‐
estradiol/testosterone ratio, FSH, LH, and 
prolactin were not significantly different in 
patients who reported sexual dysfunction 
A prospective 
study in human 
4 y (1998–
2001) 
(Collazos et al., 2002) 
PIs: saquinavir Semen alteration decreased sperm motility, and 
negatively affects mechanisms that are essential 
to fertilization of an oocyte, such as the 
acrosome reaction 
In vitro evidence 
(trial) 
… (Ahmad et al., 2011) 
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HAART Semen alteration, reductions in ejaculate volume, 
increased rates of abnormal sperm morphology, 
and decreased sperm motility 
In vitro 
evidence(Trial), 
clinical evidence 
(trial) 
… (Nicopoullos et al., 2010, 
van Leeuwen E, 2008, 
Kehl et al., 2011) 
NNRTI‐containing 
regimen: nevirapine and 
PI 
Associated with a higher percentage of 
progressively motile spermatozoa, vitality 
A Cross-sectional 
study in human 
Semen 
samples 
(Lambert-Niclot et al., 
2012) 
HAART A decline in sperm concentration, total count, 
progressive motility, and normal morphology 
… … (Nicopoullos et al., 2004) 
HAART A decrease of the rapidly progressive motile 
spermatozoa and an increase of less rapidly 
progressive spermatozoa 
… … (Dulioust et al., 2002) 
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HAART - Zidovudine, 
Lamivudine, and 
Nevirapine 
 The significant decline in sperm motility, 
decline in epithelial height closely mirrored by 
extensive reticulin framework and positive PAS 
cells.  
Animal  56 days (Ogedengbe et al., 2016) 
HAART- Lamivudine, 
Stavudine, and 
Nevirapine) 
extensive atrophy of seminiferous tubules with 
loss of cellular components depleted 
spermatogenic cell series 
Animal 56 days (Jegede et al., 2017) 
HAART- Tenofovir, 
Emtricitabine, Efavirenz 
A decrease in sperm count, increase in 
spermatozoa with normal morphology reduction 
in progressive sperm motility.  Fragmentations 
increased in tail lengths of sperm DNA. 
Reduction in  the area and diameter of the 
seminiferous tubules 
Animal 4 weeks (Adana et al., 2018) 
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HAART - Zidovudine, 
Lamivudine, and 
Nevirapine 
Tubular necrosis with detached spermatogenic 
cells from the basal lamina reduced expression 
of androgen receptor in the seminiferous tubule 
Animal 8 weeks (Ismail et al., 2017a)  
Nucleoside‐containing 
antiretrovirals 
Do not induce sperm damage but may produce 
improvements in semen quality 
Longitudinal study 
over  
12 weeks (Robbins et al., 
2001)Robbins et al, 2001 
(Robbins et al., 2001) 
 
 
Abbreviations: 3TC, Lamivudine; AZT/ZDV, Zidovudine; BEST, BID Efficacy and Safety Trial; d4T, Stavudine; ddl, Didanosine; FSH, follicle‐
stimulating hormone; IDV, Indinavir; LH, luteinizing hormone; NNRTI, nonnucleoside reverse transcriptase inhibitor; NRTI, nucleoside analogue 
reverse transcriptase inhibitor; PI, protease inhibitor; RTV, Ritonavir. 
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1.5. Reproductive Uses of medicinal herbs and natural antioxidants 
An increasing attention is being paid to traditional medicines, as they have been proved 
preventive and ameliorative in a variety of diseases. Several epidemiological studies have 
conclusively shown that consumption of fruits and vegetables are linked to significant 
reduction in the risk of developing major chronic diseases (Butt et al., 2015, Appel et al., 
1997, Rizzo and Baroni, 2018). This has been attributed to the presences of phytochemicals, 
the bioactive compounds present in plant-derived foods. It is further proven by the 
dependence of an estimated 3.2 billion people (64%) of the whole world population on 
traditional medicines (Khan et al., 2017, Sofowora et al., 2013 Studies have shown that 
almost 80% of Africans use and rely on medicinal plants for their health care needs (Goggin 
et al., 2009). Many South Africans regard medicinal plants as a safe, cheaper and desirable 
alternative to treating their health problems (McKean et al., 2018). The use of medicinal 
plants most especially in Africa for the treatment of diseases is gaining more popularity in 
the 21st century (Kayode and Kayode, 2011, Mahlangeni et al., 2014). This is consequent on 
their various biologically active phytochemicals including flavonoids (Krishnaiah et al., 
2015).  
 Commonly used medicinal herbs for reproductive health issues 
The use of herbal therapies for the management of reproductive health issues is quite popular 
in many indigenous communities around the world. Even though infertility is blamed on the 
female partner in many indigenous settings, some herbs have been recognized for their 
beneficial properties in male reproductive functions (Table 3) 
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Table 3: Commonly used Medicinal Herbs for Reproductive Health Issues 
Herb/ Plant  Active component  effect Proposed Mechanism of 
action 
Reference  
Ferula assa-
foetida L. 
volatile oil, resin, and gum, 
The resinous constituents 
include asaresinol ferulate, 
free ferulic and umbellic 
acids 
aphrodisiac activity, 
increased penile 
erections/hour, 
augmentation of sperm 
counts, 
Improvements in sperm 
motility and 
microstructure. 
The endothelial release of 
nitric oxide which 
stimulates the synthesis of 
cyclic guanosine 
monophosphate in the 
penile corpus cavernosum. 
A contributing role for an 
effect upon prostacyclin 
synthesis was suggested 
(Kassis et al., 
2009) 
Nigella sativa 
(black seeds) 
thymoquinone, dithymquinone, 
thymohydroquinone and thymol 
Increased spermatogenesis Increased androgen levels (Mohammad et 
al., 2009) 
Withania 
somnifera 
(Ashwagandha) 
alkaloids, ergostane 
steroids, amino acids, and 
neurotransmitters 
Increase semen volume, 
sperm count, and motility 
increased testosterone 
and LH 
(Ambiye et al., 
2013) 
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Panax Ginseng Ginsenosides, a class of 
natural product steroid 
glycosides and triterpene 
saponins 
Increase sperm count and 
motility 
DNA and protein 
syntheses in rat testes, 
activation of testicular 
cAMP-responsive element 
modulator, agonists of 
steroid hormone receptors 
(Seock‐Yeon et 
al., 2004, Salvati 
et al., 1996, 
Yamamoto et al., 
1977, Park et al., 
2007)   
Eurycoma 
longifolia 
(Jack) 
quassinoids, canthine-6-one 
alkaloids, triterpenes, 
squalene derivatives, 
carboline alkaloids 
Increase in semen volume, 
sperm count, and normal 
forms 
increase the testosterone 
levels in rat Leydig cells, 
antioxidant activity 
(Tambi and 
Imran, 2010, Low 
et al., 2013) 
Astragalus 
mongholicus 
Isoflavonoids (formononetin, 
ononin, calycosin, and its 
glycoside), saponins 
Increase sperm  motility protects against ROS 
toxicity through inhibiting 
the protein 
dephosphorylation 
(Hong et al., 
1992) 
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1.6. Naringenin 
Naringenin is a bitter, colourless (Nihon nogei, 1992, Abe, 2008) flavanone, a type of 
flavonoid. It is the predominant flavanone in grapefruit (Felgines et al., 2000) and is found in 
a variety of fruits and herbs (Yanez et al., 2007).  
 Chemical structure of Naringenin 
Naringenin has the skeleton structure of a flavanone with three hydroxyl groups at the 4', 5, 
and 7 carbons. It may be found both in the aglycol form, Naringenin, and in its glycosidic 
form, naringin, which has the addition of the disaccharide neohesperidose attached via a 
glycosidic linkage at carbon 7. Like the majority of flavanones, Naringenin has a single chiral 
centre at carbon 2, resulting in enantiomeric forms of the compound (Yanez et al., 2007). The 
enantiomers are found in varying ratios in natural sources (Yáñez et al., 2008). Racemization 
of S(-)-Naringenin has been shown to occur fairly quickly (Krause and Galensa, 1991a). 
Separation and analysis of the enantiomers have been explored for over 2 decades (Yanez et 
al., 2007) primarily via high-performance liquid chromatography on polysaccharide-derived 
chiral stationary phases (Krause and Galensa, 1991a, Krause and Galensa, 1991b, Gaggeri et 
al., 2011). There is evidence to suggest the stereospecific pharmacokinetics and 
pharmacodynamics profiles explaining the wide variety in Naringenin's reported bioactivity 
(Yáñez et al., 2008). 
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Figure 8: Chemical structure of Naringenin. Source: National Center for Biotechnology 
Information (https://pubchem.ncbi.nlm.nih.gov/compound/naringenin#section=Top) 
  
 
 Biological activities and potential beneficial role of Naringenin in male   
                                   Reproduction 
Naringenin is a flavanone that is considered to have a bioactive effect on human health in a 
wide range of beneficial ways.  
i. Estrogen activity modulator: while some research has shown that Naringenin 
exhibits mild anti-estrogenic activity, (Ruh et al., 1995) some have shown that it is 
able to act as a competitive antagonist in the presence of a potent agonist like E2 or 
genistein.  (Guo, 2004). It is therefore suggested that Naringenin has a double 
directional adjusting function of both estrogenic and antioestrogenic activities 
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(Diamanti-Kandarakis et al., 2009). This is what is required in the regulation of male 
reproduction as oestrogen is present in the fluid that accompanies sperm through the 
male reproductive tract. Researchers found that oestrogen plays a role in the male 
tract (Roser, 2001). It makes sperm more concentrated in semen and probably boosts 
sperm count in the ejaculate. Based on this, the small amount of oestrogen normally 
made in men is likely important for normal fertility (Eddy et al., 1996). However, it 
is well known that exposure to an excessive amount of oestrogen during foetal 
development or later in life can lead to significant problems (Newbold, 2004, 
Hileman, 1994, Sharpe and Skakkebaek, 1993, Adeel et al., 2017, Cederroth et al., 
2010, Assinder et al., 2007). 
ii. Anti-inflammatory properties: Various studies have demonstrated the anti-
inflammatory properties of Naringenin (Bodet et al., 2008, Wu et al., 2016, Maatouk 
et al., 2016). Naringenin is a potent inhibitor of the pro‐inflammatory cytokine 
response induced by lipopolysaccharide in both macrophages and in whole blood. 
Naringenin markedly inhibited the phosphorylation on serines 63 and 73 of Jun proto‐
oncogene‐encoded AP‐1 transcription factor in lipopolysaccharide‐stimulated 
macrophages (Bodet et al., 2008). The anti-inflammatory potential of Naringenin has 
been shown to be comparable to that of indomethacin, a non-steroidal anti-
inflammatory agent (Fan et al., 2017).  Naringenin is now being actively investigated 
as a possible candidate to protect against inflammatory injuries. To account for the 
diverse effects of Naringenin, it has been proposed that its biological activities involve 
downregulation of the expression of proinflammatory markers, including iNOS and 
COX-2, by reducing the activities of NF-κB (Hämäläinen et al., 2007). 
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Inflammation of the reproductive tract due to ascending infections caused by sexually 
transmitted bacteria or urinary tract pathogens are significant causes of male factor 
infertility (Schuppe et al., 2017, Fijak et al., 2018). They represent the most frequent 
aetiology of epididymo-orchitis. Growing shreds of evidence reveal that 
environmental factors such as exposure to toxicants, the parents' and individual's diet, 
and even infectious and inflammatory events in the male reproductive tract may 
influence epigenetic reprogramming. These can induce damage on the germline 
chromatin, resulting in negative consequences for fertility and health 
(Schagdarsurengin et al., 2016). 
iii. Antioxidant activity: Both clinical and animal trials have emphasized the antioxidant 
role of Naringenin in the body (Cavia‐Saiz et al., 2010). This has been demonstrated 
in several organ systems in the body including the brain, (Hegazy et al., 2016) kidney 
(Renugadevi and Prabu, 2009, Hermenean et al., 2013), liver (Arul and Subramanian, 
2013, Goldwasser et al., 2010), blood (Lee et al., 2002) and testes (Roy et al., 2013, 
Sahin et al., 2017). 
Many identifiable causes of subfertility in men (such as varicocele) and idiopathic 
cases have been linked to disruption of oxidant-antioxidant balance in the testes 
(Gharagozloo et al., 2016, Wright et al., 2014, Ma et al., 2017). 
iv. DNA protection and repair: Observations from various researchers reveal its ability 
to repair DNA (Oršolić et al., 2011, Adana et al., 2018). The hydroxyl damage 
observed in a DNA molecule was found to be significantly reduced when cells were 
exposed to Naringenin for 24 hours (National Center for Biotechnology Information) 
(National Center for Biotechnology Information).  In an in vitro study on plasmids, 
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Naringenin and another flavonoid rutin were able to protect against UV-B-induced 
DNA damage (Kootstra, 1994). 
The Mitochondrion is an intracellular organelle in control of energy metabolism in 
eukaryotic cells. In each cell, there are 100-1,000 mitochondria and about two to ten 
mitochondrial Deoxyribonucleic Acid (mtDNA) per mitochondrion (Medina et al., 
1994). The movement of sperm requires a large amount of ATP to drive the flagellar 
apparatus, thus a defect in the mitochondrial respiratory function will lead to a decline 
in its motility and consequently fertilizing potential (Sampson et al., 2001, Kumar and 
Sangeetha, 2009). Sperm mtDNA damage has been linked to oxidative stress, a 
popular explanation in the pathogenesis of many idiopathic seminal aberrations 
(Andrews et al., 1999). 
 
v. Other health benefits of Naringenin 
 
Naringenin has been shown to affects peroxisome proliferator-activated receptor 
(PPAR) alpha and PPAR gamma signalling by enhancing insulin-stimulated tyrosine 
phosphorylation and insulin tissue sensitivity (Kuiper et al., 1998, Kannappan and 
Anuradha, 2010, Goldwasser et al., 2010). Flavonoids mitigate free radical/oxidative 
stress induced tissue damage (Chen et al., 2016, Ben Salem et al., 2015). Naringenin 
has also been shown to have antiviral activities which make it a desirable adjuvant 
treatment in patients with HIV- hepatitis co-infection. It reduces hepatitis C virus 
production by infected liver cells in cell culture by inhibiting the secretion of very-
low-density lipoprotein by the cells (Nahmias et al., 2008). Reports of antiviral effects 
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on polioviruses HSV-1 and HSV-2 have also been made (Mucsi and Pragai, 1985, 
Lyu et al., 2005). 
1.7. Statement of Problem 
Since 1983 the pandemic-HIV has caused untimely deaths in over 25 million persons 
(Chandra et al., 2016). Currently, an estimated thirty-seven million persons in the world are 
affected by the Human Immunodeficiency Virus (Platt et al., 2016) and South Africa bears 
the largest burden (Kang’ethe, 2015). About 11.2% (6.3 million) of South Africans are living 
with HIV and AIDS (Kharsany and Karim, 2016). HAART has greatly improved the lifespan 
of PLWHAs with a life expectancy of 60.6 years for males and 64.3 for females (UNAIDS, 
2016). It is proposed that by 2020, 90% of individuals diagnosed with HIV will be on 
HAART (Granich et al., 2015, (UNAIDS, 2017). Unfortunately, HAART has been associated 
with deleterious organ toxicity levels especially as it affects the gonads (Bujan L, 2007, van 
Leeuwen E, 2008, Semprini AE, 2013, Azu et al., 2014). Basu (2007) reports that most 
PLWHAs are in their reproductive age. In South Africa, an estimated 16.6% of those aged 
15-49 years are HIV positive and about 48.91% are males (Basu, 2007). The consequence, 
therefore, is that most of the HIV positive men will never have the opportunity to father their 
own biological children. This vitiates the whole essence of the therapy as it deprives patients 
of the benefit of a good reproductive health. Therefore, it is of high importance that a new 
therapy is developed to attenuate these gonado-toxic effects of HAART.  
Furthermore, sequel to the fact that the success rate of the most specialized form of treating 
infertility, in vitro fertilization is still below 50% (Buzadzic et al., 2015) and intracytoplasmic 
sperm injection (ICSI) are too expensive and beyond the reach of the middle class (Agarwal 
and Allamaneni, 2005), it is only pragmatic that an effective therapy affordable and easily 
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accessible be developed. In spite of the wide application of traditional medicine among South 
Africans (Mahlangeni NT, 2014, Maroyi, 2017), there remains paucity of literature on an 
effective and easily accessible phytochemical therapy targeted at protecting the fertility of 
PLWHAs.  
1.8. Research questions 
i. What are the impacts of the recently approved first line antiretroviral therapy for 
adults FDC, TDF/FTC/EFV on the testes? 
ii. What are the ultrastructural changes that accompany the use of FDC, 
TDF/FTC/EFV 
iii. What is the effect of FDC, TDF/FTC/EFV on the expression pattern of 3 beta-
hydroxysteroid dehydrogenase? 
iv. What is the role of Naringenin in alleviating testicular perturbations induced by 
HAART?  
v. What is the effect of FDC, TDF/FTC/EFV on the reproductive capability? 
 
1.9. Aims and objectivess 
 Overall aim 
The overall aim of this study is to determine the possible beneficial effects of Naringenin on 
HAART induced testicular-toxicity. 
 Specific objectives 
i. To determine the effects of Naringenin on HAART-induced cytoarchitectural changes 
in the testis: Histomorphometric indices including the volume of germ and Leydig cells. 
ii. To investigate the effects of Naringenin on HAART-induced Sperm mtDNA 
fragmentations and progressive sperm motility.  
iii. To access the effects of HAART and Naringenin on fertility index including the fetal 
number. 
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iv. To determine the effects of Naringenin on HAART-induced testicular oxidative stress 
using intratesticular antioxidant enzyme activity: Catalase and Glutathione peroxidase 
(GSH).  
v. To determine the reproductive hormonal changes (Testosterone, Luteinizing hormone 
(LH), Follicle Stimulating Hormone (FSH) following the co-administration HAART 
and Naringenin.  
 
1.10. Potential benefits 
Available evidence indicates that by the year 2020 over 90% of PLWHAs will be on HAART 
(UNAIDS, 2014). Most of these persons will be in their reproductive age and will want to 
have their own biological children. Unfortunately, the use of HAART induces infertility. 
Ameliorating this deleterious effects of HAART will be a remarkable advancement in the 
management and treatment of HIV. 
Currently, the most specialized form of treatment of infertility has been through assisted 
reproductive techniques especially in vitro fertilization. However, availability and access to 
these techniques have been hindered by the relatively high cost.  In addition, failure rates 
have been high even when the male appears to have normal spermiograms. This has generated 
interest in studies of subcellular changes (mtDNA) in sperm cells in order to reduce the failure 
rates and congenital anomalies. Therefore, the need for developing new therapeutic measures 
for the treatment of subcellular levels of infertility is undebatable topical. More so, reducing 
mtDNA fragmentation in spermatozoa may just be the glimmer needed for the management 
and treatment of HAART related toxicities. 
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1.11. Methodology  
 Materials 
Sixty (60) adult male and 18 female Sprague-Dawley (SD) rats, weighing 200–220 g, were 
obtained from the animal house of the Biomedical Resource Unit, University of KwaZulu- 
Natal, South Africa. They were housed in standard cages under controlled environmental 
conditions (25oC and a 12-h light/dark cycle). Animals had free access to pulverized standard 
rat pellet food and tap water.  
A fixed-dose combination (FDC) containing efavirenz (EFV) 600 mg, emtricitabine (FTC) 
200 mg and Tenofovir (TDF) 300 mg was administered daily (Adult antiretroviral therapy 
guidelines 2014).  The therapeutic dose was adjusted for animal weight using the human 
therapeutic dose equivalent for a rat model. The drug was procured from Pharmacare Ltd, 
Port Elizabeth, South Africa. Naringenin was procured from Sigma Aldrich Avergelee. 
  
 Experimental Design 
The study was carried out in 2 phases- phase I and II.  
Phase I 
Phase I was conducted over a period of 4 weeks to determine the feasibility of the doses for 
the Naringenin as proposed by (Raza et al., 2013). Twenty four male Sprague Dawley (SD) 
rats were randomly divided into 6 equal number groups as illustrated in figure 9, each group 
with a different treatment protocol viz; 
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o Group A: Control (Distilled water) 
o Group B: HAART  (a fixed dose combination of Tenofovir, Emtricitabine, 
and Efavirenz) 
o Group C:  Naringenin, 40 mg/kg for 21 days (Raza et al., 2013) 
o Group D:  Naringenin, 80 mg/kg for 21 days (Raza, 2013) 
o Group E:  HAART + Naringenin, 40 mg/kg 
o Group F:  HAART + Naringenin, 80 mg/kg 
 
 
Figure 9: Experimental design 
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At end of the experiment, the animals were euthanized and the following parameters studied: 
i. Semen analysis (sperm count, sperm motility, and sperm morphology) 
ii. MDA, SOD, Catalase, and GSH 
iii. Histology of the testis 
iv. Immunohistochemical studies of 3β-Hydroxysteroid dehydrogenase (3β-HSD) 
v. Electron microscopic studies  
vi. Fertility index 
 
Phase II 
The results from the phase I study was used to determine the dosage for the main experiment 
which lasted 10 weeks. Thirty (30) adult male SD rats were randomly divided into 6 equal 
number groups as was done in the phase I. All administrations were through the oral route 
and was done between 8:00 a.m. and 10:00 a.m 
  
 Weight Determination 
Animals were weighed daily. Weights were taken in the morning between 7:30 and 9:30 prior 
to administrations. 
 
 Determination of Fertility Index 
Three female animals were introduced to three males at the end of the 10 weeks of treatment 
in phase II. Animals in each group were kept with a female animal for copulation to take 
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place. The morning on which sperm is found in the vagina lavage was designated as 
gestational day zero (gd 0) (Hafez and Hafez, 2013). Female animals were studied at day 20 
of pregnancy. The number of pregnancies and subsequently the number and size of litters per 
group were noted. Fertility index (FI) was calculated as follows: 
FI= (number of pregnancies)/(number of mated females) x 100  
  
 Animal Sacrifice and Collection of Samples  
Five days after mating each male SD rat was euthanized and blood samples were collected 
via transcardial puncture. Five millilitres (5ml) of blood sample was obtained from each rat 
and divided into two: One half in a plain bottle and the other half in an 
ethylenediaminetetraacetic acid (EDTA) bottle. Plasma and serum were obtained by 
centrifugation at 3000 rpm for 20 min (g = 9.78 m/s2). The testes were excised and fixed in 
either 4% paraformaldehyde, glutaraldehyde or Bouin`s fluid for immunohistochemistry, 
electron microscopic and histological analyses respectively. The cauda epididymis was 
assayed for sperm count, sperm motility, and sperm morphology.   
1.11.6 Histomorphological Study  
For histopathological examination, testes tissues were subjected to systematic serial 
sectioning at 4µm intervals using a microtome (Microm HM 315, Germany). Samples were 
then processed using a graded ethanol series and embedded in paraffin (see appendix II). The 
paraffin sections were cut into 4µm-thick slices and stained with hematoxylin and eosin (H 
& E) for histological examination (Sukumaran and Raveendranath, 2012). The sections were 
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viewed and photographed using an Olympus light microscope (Olympus BX51, Tokyo, 
Japan) with an attached camera (Olympus E-330, Olympus Optical Co. Ltd., Japan).  
 
1.11.6 Ultrastructural Study 
Transmission electron microscope (TEM) was used to further provide a more detailed 
morphologic and compositional information on samples (most especially Sertoli-Sertoli cell 
junctions). This was done after the tissues were fixed overnight at 4oC in 3% glutaraldehyde 
in 0.1 M sodium cacodylate buffer (pH 7.4) and transferred to 0.1 M phosphate buffer (pH 
7.2). The cells were postfixed in 1% osmium tetroxide in S-collidine, dehydrated in graded 
ethanols, transferred to propylene oxide, and embedded in Epon 812. Semi-thin sections were 
obtained stained with 1% methylene blue. The samples were further sectioned into ultrathin 
slices (75nm thick) on the cutting edge of glass knives using Leica EM UC7 Ultramicrotome 
(Austria), mounted on copper grids and contrasted with uranyl acetate and lead citrate 
(Bressenot et al., 2009) and observed on a transmission electron microscope examined under 
JEOL JEM-1010 transmission electron microscopy (TEM) at magnification 1000 to 
20,000nm in the Microscopic and Microanalysis Unit (MMU) of the University of KwaZulu-
Natal, Westville campus. 
 
1.11.7 Relative organ weight  
The relative organ weights were calculated for the testis using the following formula: 
                               (Organ weight)/ (Total body weight) X 100 
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1.11.8 Biochemical Estimation for Oxidative Stress levels    
One testis from each rat was homogenized using a Teflon homogenizer (Heidolph Silent 
Crusher M) and then the homogenates were centrifuged at 10,000g at 4ºC for 15 min. 
Homogenized tissues were used for catalase (CAT) and glutathione peroxidase (GSH-Px) 
assay using standard Enzyme-Linked Immunosorbent Assay (ELISA) (See appendix IV and 
V).   
1.11.9  Immunostaining of Testis    
The testis was immunostained for (3β-HSD) in accordance with reports from (Makala et al., 
2014, Devi et al., 2016). Testes tissues were taken from Bouin’s fluid and transferred to 70% 
ethanol (Latendresse et al., 2002). They were then processed using a graded ethanol series 
and embedded in paraffin. The paraffin sections were cut into 4 µm-thick slices using a 
microtome (Microm HM 315 microtome, Walldorf, Germany). Immunohistochemistry was 
performed using Santa Cruz 3β HSD primary antibody and Dako Envision FLEX kit. The 
processed and sectioned tissues were dewaxed with 2 changes of xylene and hydrated with 
decreasing grades of alcohol, and water. The sections were placed in diluted Envision FLEX 
Target solution for 20 minutes at 95-99oC. Tissue sections were washed in wash buffer, 
blocked with peroxidase and incubated with diluted 3β HSD (1:150) from Santa Cruz for 30 
minutes and with HRP for 20 minutes, DAB and counterstained in hematoxylin, washed in 
wash buffer, dehydrated, cleared and mounted on DPX. The sections were viewed and 
photographed using a 40X objective (Zeiss  Axioscope  A1 microscope, Carl Zeiss, Germany) 
with an AxioCam MRc Zeiss digital camera attached.  
In order to determine the percentage immunoreactivity, image analysis and capturing was 
done using AxioVision software (Carl Zeiss, Germany; version 4.8.3). At least six fields of 
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view per slide were randomly selected and captured using a 20X objective. 3β HSD 
expression was determined as percentage of immunostaining (brown) within the interstitium 
of the testis. 
 
1.11.10 Sperm characteristics  
Sperm count, motility, and morphology were accessed in accordance with the method 
reported previously (Rezazadeh-Reyhani et al., 2015, Jalali AS, 2015). Briefly, Epididymal 
spermatozoa were collected from the cauda epididymis in 1 ml of normal saline and incubated 
for 10 minutes at 37oC in an atmosphere of 5% CO2 incubator to allow sperm to swim out of 
the epididymal tubules. In order to assess the sperm motility, one drop of sperm suspension 
was placed on a microscope slide, and a cover slip placed over the droplet. At least 10 
microscopic fields were observed at 400x magnification using a phase contrast microscope.  
The epididymal sperm counts were obtained by the standard hemocytometer. Briefly, after 
dilution of epididymal sperm to 1:20 in normal saline, approximately 10 μl of this diluted 
specimen was transferred to each of the counting chambers of the hemocytometer, which was 
allowed to stand for 5 minutes in a humid chamber to prevent drying. The cells sedimented 
during this time and were counted using Biorad® automated cell counter 1450101TC 20TM 
with a double slide counting chamber. The dilution was mixed thoroughly and both sides of 
the counting chamber were scored and the average of the two counts were taken and sperm 
count expressed in millions/ml (Keel and Webster, 1990). Sperm morphology was accessed 
by staining dry smeared sperm on a glass slide with eosin-nigrosin staining and observing 
under a light microscope. 
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1.11.11 Determination of Reproductive hormones  
The serum levels of LH, FSH and testosterone were determined by enzyme immunoassay 
using standard kits (Oremosu and Akang, 2015) (See appendix VI, VII and VIII). 
1.11.12 Sperm mitochondrial DNA fragmentation and deletion test 
Epididymal sperm samples were collected for sperm Total DNA fragmentation analysis by 
means of Comet assay. DNA damage was assessed using the Comet assay with minor 
modifications (Singh et al., 1988). Two slides per sample were prepared. The first layer 
consisted of 2% low melting point agarose (LMPA, 37 °C). A second layer of 10 lL of rat 
spermatozoa from each sample with 1% LMPA (37 °C) and a volume of 1 lL of GelRedTM 
nucleic acid gel stain (Biotium, California, cat. no. 41003) were added. A third layer of 1% 
LMPA (37 °C) was then added. Once solidified, the slides were submerged in cold lysing 
solution [2.5 M NaCl, 100 mM EDTA, 1% Triton X-100, 10 mM Tris (pH 10), 10% DMSO] 
and incubated (4 °C, 1 h). Following incubation, the slides were placed in electrophoresis 
solution [300 mM NaOH, 1 mM Na2EDTA (pH 13)] for 20 min and thereafter 
electrophoresed (25V, 35 min, RT) using Bio-Rad compact power supply. The slides were 
then washed 39 (5 min each) with neutralization buffer [0.4 M Tris (pH 7.4)]. The slides were 
viewed with a fluorescent microscope (Olympus IX51 inverted microscope with 510–560 nm 
excitation and 590 nm emission filters). Images of 50 cells/comets were captured per sample 
and the comet tail lengths (lm), Tail Moment (a.u.), and tail DNA (%) were measured (Olive 
& Banath, 2006; Gyori et al., 2014) using Soft imaging system (Life Science – ©Olympus 
Soft Imaging Solutions v5) and CASPLAB – COMET ASSAY SOFTWARE (v1.2.3beta2), 
Poland. 
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1.11.13 Statistical Analysis 
The data were presented as mean ± SEM. The differences were evaluated using one-way analysis 
of variance (Ciz et al., 2012) followed by Fisher’s Least Significant Difference (LSD) procedure 
for multiple comparisons. P<0.05 was considered statistically significant. The Statistical Package 
for Social Sciences (SPSS) version 23 was used for the analysis. 
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1.12 Summary of the manuscripts/Publication 
Table 4: Summary of the manuscripts/Publication 
SN     TITLE  JOURNAL REMARK 
 
1. Naringenin attenuates highly active 
antiretroviral therapy-induced 
sperm DNA fragmentations and 
testicular toxicity in Sprague- 
Dawley rats 
Andrology 
(doi: 10.1111/andr.12439) 
Published 
2. Testicular Microanatomical and 
Hormonal alterations 
following use of Antiretroviral Therapy 
in Sprague-Dawley 
rats: the role of Naringenin 
Andrologia  
(doi: 10.1111/and.13137) 
 
Published 
3. Antiretroviral therapy induced 
impaired Sertoli cell function and 
testicular antioxidant activity: the role 
of Naringenin 
Archives of Medical 
Sciences 
Under 
review 
4. Testicular 3 Beta hydroxysteroid 
dehydrogenase in Naringenin under 
Highly Active Antiretroviral Therapy 
(HAART): preliminary data using 
Sprague-Dawley rats 
European Journal of 
Anatomy (in press) 
 
 
Accepted 
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BRIDGING 
BETWEEN CHAPTERS ONE AND TWO 
 
An intact Hypothalamo-pituitary-testicular axis (HPT) made up of anatomic tissues as well 
as biochemical agents secreted is necessary for optimal spermatogenesis. The previous 
chapter reviewed the literature on the male reproductive system and the causes of male factor 
infertility. An overview of HIV/AIDS as a disease, the drug management of HIV and 
deleterious effects of antiretroviral therapy in impacting on the fertility potentials of men was 
subsequently highlighted, however the mechanism of damage and hence protective agents 
are yet to be deciphered. Phytochemicals in various medicinal plants have been getting a lot 
of attention in recent times. Their possible role in the management of infertility is being 
investigated. The next chapter went ahead to confirm the findings of earlier researchers and 
further highlight the mechanism of injury caused by the short-term effects of antiretroviral 
therapy on the testicular microanatomy using stereological methods, assay of reproductive 
hormones as well as its effects on the sperm mitochondrial DNA. 
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BRIDGING 
BETWEEN CHAPTERS TWO AND THREE 
The previous chapter described the short-term damaging effects of HAART on the sperm 
DNA and the testicular microanatomy using Sprague Dawley rats. Currently, there has not 
been a cure for HIV and the new WHO guideline recommends the commencement of 
antiretroviral drug soon after diagnosis in all individuals irrespective of age, gender, CD4 
lymphocyte cell count nor viral load. The use of antiretroviral therapy is, therefore, a lifelong 
issue in people living with HIV/AIDS. Many of these people are in their reproductive age 
group and are likely to desire their own biological children at some point in their lives. This 
informed the second phase of the study in which effects of long-term use of HAART on the 
testicular histoarchitecture as well as the Hypothalamo-pituitary testicular (HPT) axis was 
studied.  
  
  
124 
 
 
3 CHAPTER THREE 
MANUSCRIPT TWO 
Testicular Microanatomical and Hormonal alterations following use of 
Antiretroviral Therapy in Sprague-Dawley rats: role of Naringenin 
Misturah Yetunde Adana 1,2*, Edidiong Nanso Akang 1,3, Edwin Coleridge Stephen 
Naidu 1, Peter Imo Aniekan 1,4,  Koffi Kouame1, Offor Ugochukwu1, 
Oluwatosin Olalekan Ogedengbe1, Onyemaechi Okpara Azu.1,5 
  
1Discipline of Clinical Anatomy, School of Laboratory Medicine and 
Medical Sciences, University of KwaZulu-Natal, Durban, South Africa 
2Department of Anatomy, Faculty of Basic Medical Sciences, College of Health Sciences, 
University of Ilorin, Ilorin, Nigeria. 
3Department of Anatomy, College of Medicine, University of Lagos, Lagos, Nigeria. 
4Department of Anatomy, Faculty of Basic Medical Sciences, University of Uyo, Uyo, 
Nigeria 
5Department of Anatomy, School of Medicine, Windhoek, Namibia 
  
Published in Andrologia: 20-September-2018 (DOI: 10.1111/and.13137) 
Accepted: 29-July-2018 
 
125 
 
  
126 
 
 
 
127 
 
 
 
128 
 
 
  
129 
 
 
  
130 
 
 
  
131 
 
 
  
132 
 
 
  
133 
 
 
  
134 
 
 
  
135 
 
 
136 
 
BRIDGING 
 BETWEEN CHAPTERS THREE AND FOUR  
 
Chapter three addresses the effects of antiretroviral therapy used over a longer period that 
lasts 10 weeks on the testicular microanatomy using histologic and histomorphometric 
methods. The changes associated were compared to changes in semen parameters (sperm 
count, sperm motility and percentage with normal morphology) alterations in the serum level 
of reproductive hormones. The flavonoid, Naringenin was administered to reverse/ protect 
against reproductive toxicity. This was done by checking the pregnancy rates following 
administration of drugs and phytochemical extract. The chapter reports alteration in semen 
parameters as well as testicular histoarchitecture. This suggests an underlying Sertoli cell 
dysfunction. Next chapter describes the testicular ultrastructure following the use of HAART 
as wells as the testicular antioxidant exam activity, an important protective mechanism in the 
male gonads.  
  
137 
 
4 CHAPTER FOUR 
MANUSCRIPT THREE 
Antiretroviral therapy induced impaired Sertoli cell function and testicular 
antioxidant activity: the role of Naringenin 
1,2*Misturah Yetunde Adana, 3Edidiong Nnamso Akang, 1Dr Edwin Coleridge Naidu, 4John 
Miller Basgen, 1,5Professor Onyemaechi Okpara Azu 
1Discipline of Clinical Anatomy, School of Laboratory Medicine and Medical Science, 
Nelson R Mandela School of Medicine. University of KwaZulu-Natal 
2Department of Anatomy, Faculty of Basic Medical Sciences, College of Health Sciences, 
University of Ilorin, Ilorin, Nigeria 
 3Department of Anatomy, College of Medicine, University of Lagos, Lagos, Nigeria 
4Morphometry and Stereology Laboratory, Charles R. Drew University of Medicine and 
Science, Los Angeles, California USA 
5Department of Anatomy, School of Medicine, Windhoek, Namibia 
 
Submitted to Archives of Medical Sciences (AMS-08220-2018-01): 08-May-2018 
 
 
  
138 
 
Antiretroviral therapy induced impaired Sertoli cell function and testicular 
antioxidant activity: the role of Naringenin  
Abstract  
Background: Highly Active Antiretroviral Therapy (HAART) induced histopathological 
changes in the testes has been linked to increased activity of reactive oxygen species that 
ultimately overwhelms the tissue`s total antioxidant status.  
Objective: This study investigated testicular ultrastructural changes and antioxidant enzyme 
activity following use of antiretroviral therapy and Naringenin, a bioactive in Sprague Dawley 
rats.   
Materials and Methods: Thirty male Sprague Dawley rats weighing 200–220g, were assigned 
into 6 groups; DW: Distilled water, H: HAART, N40: Naringenin, 40 mg/kg, N80: Naringenin, 
80 mg/kg, HN40:  HAART+Naringenin, 40 mg/kg and HN80: HAART+Naringenin, 80 mg/kg. 
Oxidative enzyme activities were assayed using enzyme linked immunoassay and testicular 
ultrastructural changes were noted via electron microscopy.   
Results: Results revealed that the testicular glutathione peroxidase levels were lower in H 
(P=0.000), HN40 (P=0.001) and HN80 (P=0.016) than DW.  Catalase activity in H group was 
significantly lower than groups DW (p=0.024) and N80 (p=0.003). Group H displayed abnormal 
ultrastructural appearance including distortion of cellular progression in the germinal epithelium, 
degeneration of nuclear membrane and widening of internuclear space of Sertoli cells. Co-
administration of Naringenin restored the normal cellular progression. 
Discussion: Sertoli cell dysfunction has been identified as a manifestation of testicular toxicity 
from free radicals. Electron donation and possibly mop up free radicals are the proposed 
mechanism underlying the restoration of the oxidant-antioxidant balance in the testes. 
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Conclusion: This study suggests that HAART has deleterious effects on testicular function and 
male fertility. Naringenin, a bioflavonoid may be a useful adjuvant therapy in protecting against 
testicular toxicity. 
Keywords: testis; antiretroviral therapy; glutathione; catalase; spermatogenic series; Sertoli 
cell  
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Introduction 
The testes, an organ straddled with dual functions of steroidogenesis and sperm production 
is greatly dependent on oxygen to drive spermatogenesis and yet extremely vulnerable to 
the toxic effects of reactive oxygen metabolites (1-3). As a result the testis devises an 
efficient antioxidant systems involving both enzymatic and non-enzymatic components. 
The enzymatic component is activated during the process of spermatogenesis. At this time 
superoxide anion (O2 -) is generated from high rates of mitochondrial oxygen consumption 
by the germinal epithelium. This is then converted to hydrogen peroxide (H2O2) in the 
presence of superoxide dismutase (SOD) in order to prevent the superoxide anion from 
forming the highly toxic hydroxyl radicals. The H2O2 generated is also a powerful 
membrane permeant oxidant which must be promptly removed from the cell so as to limit 
oxidative damage to lipids, proteins and DNA. The elimination of H2O2 is either achieved 
by catalase or glutathione peroxidase activity (4, 5). 
The seamless oxidant-antioxidant balance in the testes may be perturbed by a number of 
factors. These factors induce a state of oxidative stress in the testes. Free radical injury is 
currently being regarded as the most significant cause of impaired testicular function 
associated with the pathogenesis of many male factor infertility ranging from varicocele (6), 
to diabetes (7, 8), testicular torsion  (9, 10), xenobiotic exposure (11-13) as well as 
idiopathic cases (14-17). In a study inducing testicular torsion in animal models, severe 
histopathological damage, indicated by oxidative stress index and oxidants 
(malondialdehyde and total oxidant status) were increased with an attendant decrease in the 
antioxidants (glutathione peroxidase and total antioxidant status) in the torsion/detorsion 
group (10).   
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Antiretroviral therapy has been associated with deleterious histopathological changes in the 
testes causing tubular atrophy and altered morphometric manifestations (18-20). An 
ultrastructural study of rats’ testes administered with a combination of antiretroviral drugs 
revealed significant increase in the basement membrane (BM) thickness when compared 
with control group. The  HAART-treated group showed mitochondrial cristae collapse, and 
Sertoli cells cytoplasmic vacuolations (21). This study investigated testicular ultrastructural 
changes and antioxidant activity following use of antiretroviral therapy and Naringenin, a 
bioactive flavonoid in Sprague Dawley rats. 
Materials and Methods 
Materials 
Thirty (30) adult male weighing 200–220g, were obtained from the animal house of the 
Biomedical Resource Unit, University of KwaZulu- Natal, South Africa. They were housed in 
standard plastic cages. Animals were kept under controlled environmental conditions (25oC and 
a 12-h light/dark cycle) and they had free access to pulverized standard rat pellet food and tap 
water. Animal care and handling was in accordance with the National Institutes of Health guide 
for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978).  
A fixed dose combination (FDC) of HAART containing Efavirenz (EFV) 600 mg, Emtricitabine 
(FTC) 200 mg and Tenofovir (TDF) 300 mg was procured from Pharmacare Ltd, Port Elizabeth, 
South Africa and administered to rats daily (Adult antiretroviral therapy guidelines 2014).  The 
dose of the FDC was adjusted for animal weight using the human therapeutic dose equivalent for 
a rat model (7.5/5/15 mg/kg).  Naringenin was procured from Sigma Aldrich Avengelee. 
Experimental Design 
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 Thirty SD rats were randomly divided into 6 equal number groups viz- Groups DW served as 
control and was given distilled water, H was given the FDC of HAART containing 
TDF/FTC/EFV,   N40 had Naringenin, 40 mg/kg, N80 had Naringenin, 80 mg/kg. The last two 
groups, HN40 and HN80 had TDF/FTC/EFV and Naringenin 40mg/kg and 80mg/kg 
respectively. 
 All administrations were through the oral route and were done between 8:00 a.m. and 10:00 a.m. 
for a period of 10 weeks. Animals were weighed on alternate days for dose adjustments.  
 
Animal Sacrifice and Collection of Samples 
Following 10 weeks of treatment, the rats were euthanized. The testes were excised, weighed and 
fixed in glutaraldehyde for ultrastructural analysis.  
 
Ultrastructural Studies  
The tissues were fixed overnight at 4oC in 3% glutaraldehyde in 0.1 M sodium cacodylate buffer 
(pH 7.4) and transferred to 0.1 M phosphate buffer (pH 7.2). The cells were postfixed in 1% 
osmium tetroxide in S-collidine, dehydrated in graded ethanols, transferred to propylene oxide, 
and embedded in Epon 812. Semi-thin sections were stained with 1% methylene blue. The 
samples were further sectioned into ultrathin slices (75 nm), contrasted with uranyl acetate and 
lead citrate and observed on a transmission electron microscope (Bressenot et al., 2009)  
 
Biochemical Estimation for Oxidative Stress levels 
One testis from each rat was homogenized using a Teflon homogenizer (Heidolph Silent Crusher 
M) and then the homogenates were centrifuged at 10,000g at 4ºC for 15 min. Homogenized 
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tissues were used for catalase (CAT) and glutathione peroxidase (GSH-Px) assay using 
standardised Elabscience enzyme-linked immunoassay (ELISA) rat specific kits with catalog 
numbers: E-EL-R2456 and E-EL-R2491 respectively.  
 
Statistical Analysis 
The data was presented as mean ± standard error of mean (SEM). The statistically 
significance of differences were evaluated by using one-way analysis of variance 
(ANOVA) followed by Fisher’s Least Significant Difference (LSD) procedure for multiple 
comparisons. P≤0.05 was considered statistically significant and ≤ 0.01, very significant 
using SPSS version 23 for windows.
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Results 
Antioxidant enzymes 
The testicular glutathione peroxidase levels was higher in the N40 and N80 groups when 
compared to H group. Lower levels were also observed in groups DW, HN40 and HN80 
when compared to Naringenin-only groups. The N80 group showed significantly higher level 
of testicular catalase activity than groups DW (p=0.024) and H (p=0.003) see fig 1 and fig 2. 
The level in the HN40 was significantly higher than that of H (p=0.019).           
Ultrastructural study 
Group DW (Distilled water ) 
Basal and ad luminal compartments 
Ultrastructure of control group (DW) displays cells in the different stages of maturation. 
Early and late cellular stages of spermatogenesis are presented with well circumscribed 
nuclear membrane. The Sertoli cells are seen with prominent nucleolus next to the myoid 
cells of the BM with normal thickness. The primary spermatocytes appear rounded with 
large nuclei [Fig. 2 (a) - (d)]. The germinal epithelium depicting normal testicular 
architecture with orderly progression of cells of the spermatogenic series is indicative of 
active spermatogenesis. Shown in Fig. 2 (e) - (g) are the ad luminal compartments 
displaying round and elongating late spermatids surrounded by residual cytoplasm with 
several microtubules of the midpieces, suggesting  multiple spermatozoa. Each piece 
depicts a typical flagella axonemes composed of an array of microtubules, containing nine 
doublets arranged radially around two single central ones. Mitochondria sheaths are seen in 
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the mid pieces. Also observed are the lysosomes, ribosomes, smooth endoplasmic 
reticulum.  
Interstitium 
The interstitium houses the interstitial cells of Leydig (Ly) with nucleus having slight 
indentation and rich in euchromatin. The nuclear membrane is lined by a rim of 
heterochromatin. A large lymphatic vessel is seen traversing the interstitium. There was 
abundance of mitochondria and lipid droplets suspended within the cytoplasm of the Leydig 
cell. Other organelles such as lysosomes and smooth endoplasmic reticulum are dispersed 
in the Leydig cell cytoplasm. [Fig. 2 (h) - (i)].  
Group H (HAART)  
Basal and ad luminal compartments 
Shown in Fig. 3 are the electron micrographs of ultrastructural sections of seminiferous 
tubule portion of group H. This group has several ultrastructural abnormalities. There are 
alterations in the normal progression of cells in the germinal epithelium. The more matured 
cells belonging to the ad luminal compartment - early and late spermatids appear in the 
basal compartment.  The outline of the BM displays irregularities and increased thickness 
with hypertrophied myoid cells. There is widening of the internuclear space between Sertoli 
cells and there are scanty spermatogonic cells along the BM [Fig. 3 (a) - (d)]. Seen are 
spermatocytes showing discontinuous nuclear membrane indicating degenerative processes 
in the cells. Also observed are abnormally formed spermatid heads. The axonemes of the 
midpieces appears disorganised in cross section. The germinal epithelium appeared scanty 
with spermatocytes surrounded by abundance of residual cytoplasm suggestive of germ cell 
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atrophy. Cross section through the tail of the spermatozoa revealed axonemal defects in the 
form of lost organizations [Fig. 3 (e) - (h)]. 
Interstitium 
The interstitium presents Leydig cells appearing smaller with reduced nuclear diameter and 
slight nuclear indentation [Fig. 3(i)].  There is less euchromatin within the nucleus and the 
cytoplasm appeared scantier with fewer suspended organelles.  
Group N40 (Naringenin 40mg/kg) 
Basal and ad luminal compartments 
Ultrastructural sections of the testes of rats in N40 (Naringenin 40mg/kg) were similar to 
DW, showing normal progression of cells of the spermatogenic series. The spermatogonia 
and Sertoli cells were resting on BM. The cells have well circumscribed nuclei. The BM 
demonstrates normal thickness and the myoid cells. [Fig. 4 (a) - (c)]. The different stages of 
development of the spermatids were seen. The round spermatids and the late spermatids 
(LSt) were observed displaying normal appearance. The residual cytoplasm of the late 
spermatids were present close to the lumen with the midpieces suspended within. The 
nuclei appeared to be rich in euchromatin [Fig. 4 (d) - (f)]. 
Interstitium 
The Leydig cells are seen with slight nuclear indentations. The nucleus appeared large and 
rich in euchromatin. There is an abundance of cellular organelles suspended within the 
cytoplasm. Blood vessel were observed traversing the interstitium [Fig. 4 (g) - (i)]. No 
vacuolation observed. 
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Group N80 
Basal and ad luminal compartments 
Electron sections of the testes of rats in N80 (Naringenin 80mg/kg) showing normal 
progression of cells of the spermatogenic series. The spermatogonia and Sertoli cells are 
aligned along the BM. Cells have well circumscribed nucleus and normal internuclear 
space. The BM demonstrates normal thickness. Also seen are the primary spermatocytes 
[Fig. 5 (a) - (d)]. The cross section of the ad luminal compartment revealed a large 
population of spermatozoa tails close to the lumen showing midpieces and flagellum made 
up of the principal pieces and the end pieces. The axonemes of the pieces are well 
organised. Also seen are the residual cytoplasm and vacuoles accommodating the midpieces 
[Fig. 5 (e) - (g)].  
Interstitium 
The Leydig cells (Ly) are seen in the interstitium. The nuclei are large and rich in 
euchromatin. The cells possess abundant mitochondria and lipid droplets within their 
cytoplasm. A large blood vessel is seen containing red and white blood cells in the 
interstitium [Fig. 5 (h) - (i)]. Other cell types are observed within the interstitial tissue. 
Group HN40 
Basal and ad luminal compartments 
Observation from testes of HN40 group presented some improvement in the ultrastructural 
appearance when compared to the H group. Electron sections show Sertoli and 
spermatogonic cells lined along the BM. The myoid cells of the BM are in close relation 
with the spermatogonic cells. There is slight thickening of the BM.  The primary 
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spermatocytes presents with some degenerative changes in the nuclear membrane [Fig. 6 (a) 
- (f)]. The cross section of the tails of late spermatids shows the midpiece, principal piece 
and end piece.  There are a few midpieces with disorganised axonemes and abnormal 
spermatid heads [Fig. 6 (g) - (h)].  
Interstitium 
The Leydig cells appear with deep nuclear indentations. Nuclei present with normal 
chromatin condensations. Cytoplasmic organelles are seen suspended. Blood vessels are 
seen traversing the interstitium. Improvement on observations from the H group was noted 
[Fig. 6 (i)].  
Group HN80 
Basal and ad luminal compartments 
Ultrastructure of testes of group HN40 reveals normal progression of cells of the 
spermatogenic series. The Sertoli and Spermatogonic cells lie on the BM with myoid cells 
in the adjacent BM. The BM has a relatively straight outline with slight thickening [Fig. 7 
(a) - (d)]. Round spermatids displays acrosomal cap and occasional degeneration of nuclear 
membrane. The Late spermatids in the process of spermiation are observed. The lumen of 
seminiferous tubule contains cross section of tails showing abundant midpieces and 
principal pieces. There is some residual cytoplasm around the midpieces. Occasional 
abnormal forms in the late spermatids were observed [Fig. 7 (e) - (h)].  
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Interstitium 
Leydig cells lie amidst scanty cytoplasmic organelles. There is reduced chromatin 
condensation. No vacuoles were observed. There is slight nuclear indentation in the Leydig 
cells [Fig. 7 (i)].  
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Discussion 
ART is recommended for all individuals with HIV, regardless of CD4 cell count, to reduce 
the morbidity and mortality associated with HIV infection and to prevent 
transmission. Commencement of Highly Active Antiretroviral Therapy (HAART) however 
mean lifelong use despite the organotoxic properties of the regimen. This study describes 
antiretroviral therapy- induced alterations in testicular ultrastructure and antioxidant activity 
of adult male Sprague Dawley rat and evaluated the possible protective role of Naringenin. 
In this study, administration of HAART was associated with a reduction in the activity of 
testicular antioxidant enzymes. The testicular activity of glutathione peroxidase and catalase 
improved with the co-administration of Naringenin and HAART in a dose dependent 
manner. The improved activity of antioxidant enzymes in tissues may explain the earlier 
identified free radical scavenging properties of Naringenin as previously described. (22-24) 
In a manner similar to Naringenin, Rutin, a citrus flavonoid has been shown to increase 
testicular Glutathione peroxidase and Glutathione activities in a dose‐dependent manner. 
(25, 26) 
Germ cell injury has been identified as the most important morphologic event underlying 
testicular dysfunction following administration of cytotoxic compounds. These 
morphologic changes usually offer an explanation of the mechanism of action of the 
gonadotoxic agent. (27, 28) This study revealed alteration of the normal ultrastructure of the 
testes with use of HAART. This was evidenced by irregular contour and thickening of the 
BM. A result of cellular infiltration of the BM. Tubular degeneration has been linked with 
thickening of BM by hindering metabolic exchange between the germinal epithelium and 
the interstitium(29) A thickened BM is a common finding associated with the degeneration 
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in the seminiferous tubule of crypto-orchid testes. This has been linked to impaired 
metabolic exchange and subsequently gonadotrophin deficiencies.(30, 31) Similar 
pathology has been noted in other atrophic testes with a different aetiology (32). The altered 
exchange of materials within the testicular tissue will further induce BM infiltration and 
hence thickening.  Aging is another situation related to a convoluted and thickened BM(33). 
An increase in the expression of BM genes has been implicated in this process. This was 
found to precede atrophy of the seminiferous tubules .(33) Both the seminiferous tubule and 
the myoid cells are required for appropriate deposition of BM in the testes, an abnormality 
in the BM may suggest a malfunction of either the myoid cell or Sertoli cell.(33)  
The normal progression of the cells in the seminiferous germinal epithelium was altered 
following use of antiretrovirals. This was evidenced by the presence of elongating 
spermatids being retained and resorbed into basilar Sertoli cell cytoplasm within the basal 
compartment. Other studies that described the morphologic changes in the rat testes such as 
spermatid retention and degeneration of cells linked it with decreased intratesticular 
testosterone levels. (34, 35) 
The spermatogonic cells along the BM was observed to be scanty following the use of 
HAART. However the Sertoli cells seem unaffected, there was an associated reduction in 
the population of primary spermatocytes. The spermatocytes and round spermatids 
displayed incomplete nuclear membrane. This suggests some degenerative process ongoing 
within the cell. It has also been observed that Sertoli cell injury is expressed by loss of 
function rather than loss of Sertoli cells themselves. The many roles that Sertoli cells play 
in spermatogenesis are reflected in the variety of morphologic manifestations associated 
with Sertoli cell toxicity. An impaired Sertoli cell function expresses as germ cell 
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degeneration. Similarly degeneration of seminiferous epithelium may either present as 
endocrine toxicity or direct germ cell injury following penetration of the toxic compound 
through the blood testis barrier. (36) 
The co-administration of Naringenin proved beneficial. The normal cellular progression 
was observed and cells of the spermatogenic series were well represented however there 
were occasional defects in the continuity of the nuclear membrane. This restorative 
potential associated with use of high dose Naringenin is in tandem with earlier 
observations. (20)  Kwatra et al (2016) revealed that naringin usage, a closely related 
flavonoid ameliorated the behaviour alternation in Doxorubicin treated rats, oxidative 
stress, proinflammatory cytokines, mitochondrial dysfunction and improved monoamines 
contents in brain hippocampus of rats (37). Addition of Naringenin to oseltamivir treatment 
improved the neurofunctions of the brain through improving the Y maze task and 
reductions in the pathophysiological effect of oseltamivir. This was attributed to increasing 
total antioxidant capacity, brain fatty acid binding proteins FABP7 and Ca-ATPase and 
reducing oxidative (38). In the same study Naringenin was proposed to have reduced total 
nitric oxide, total oxidant capacity and total cytochrome P450 (CYP450) contents (38).  
Some studies have proposed an improvement in the antioxidant activity. Supplementation 
of Naringenin and its synthetic derivative enhanced antioxidant enzyme activities of 
erythrocyte and liver in high cholesterol-fed rats by enhancing the antioxidant defence 
system (24).  In cisplatin-Naringenin combined treated rats , the activities of superoxide 
dismutase, glutathione peroxidase, and catalase were significantly increased (23).  
Naringenin has also been regarded as a chelating agent capable of binding to toxic metal 
ions to form complex structures which are easily eliminate from intracellular or 
153 
 
extracellular spaces. Cavia-Saiz et al (2010) reveals that Naringenin acts as an active 
chelator of metallic ions and inhibitor of the enzyme xanthine oxidase. These ameliorative 
effects of Naringenin may be attributed to its chemical structure. The hydroxyl groups 
present are able to donate electrons and mop up generated free radicals from the altered 
oxidative status thereby restoring the oxidant-antioxidant balance in the testes. This 
provides an insight into the mechanism of gonadotoxic effect of antiretroviral therapy. 
Ranawat et al (2017) however revealed opposing views when Naringenin was administered 
intraperitoneally to mice.  They suggested that Naringenin despite being a potent 
antioxidant may also act as pro-oxidant in a dose dependent fashion, hence causing 
damaging effects in the testes observed as decreasing sperm motility as well as 
concentration and inducing alterations in testicular histomorphology (39). This difference 
can be attributed to the increased bioavailaibility of Naringenin using the intraperitoneal 
route. Additionally, the Naringenin vehicle used in the study Dimethyl sulfoxide exhibit a 
range of pharmacological activity including ability to penetrate biological membranes 
increasing the concentration of pharmacological agents within the tissue. 
Conclusion 
The present study reports that HAART induced ultrastructural changes in the testicular 
tissue due to Sertoli cell dysfunction and altered antioxidant activity in the testes of adult 
rats. The mechanism of injury is similar to those observed in cryptorchidism and aging. 
Some restoration of structure and function was achieved by Naringenin, a bioactive 
flavonoid. Researchers suggests that the protective potential of Naringenin in ART induced 
gonadotoxicity might be due to its antioxidant and metal chelating properties, which could 
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present it as a useful adjuvant in the treatment of HIV patients especially those desirous of 
future fertility. 
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(a)                                                            (b) 
 
 
 
 
 
 
Fig. 1 (a) Testicular glutathione peroxidase and (b) Catalase in groups DW (control), H (HAART), 
N40 (Naringenin 40mg/kg), N80 (Naringenin 80mg/kg), HN40 (HAART + Naringenin 40mg/kg) and 
HN80 (HAART + Naringenin 80mg/kg) after 10 weeks of treatment. Bars indicate mean±SD. α 
represents significant difference (p<0.05) between the group and control, 
ß 
represents significant 
difference between the group and H group. ßß represents very significant difference (p<0.01) between 
the group and H group. 
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Figure 2: Ultrastructure of group DW (control) depicts normal testicular architecture with 
orderly progression of cells of the spermatogenic series (a) shows early and late cellular 
stages of spermatogenesis with well circumscribed nuclear membrane (b) shows the Sertoli 
cell (Se) with prominent nucleolus (c) seminiferous tubule with BM (Bm), myoid cells 
(My) (d) shows the BM with normal thickness (e), (f) and (g) show elongating late 
spermatid (St) surrounded by residual cytoplasm and midpieces,  several microtubules of 
the midpiece (Mp) (h) and (i) show the interstitium (In) containing the interstitial cells of 
Leydig (Ly) with nucleus having slight indentation, blood vessel (Bv) containing red blood 
cells and lymphocytes. Also seen is the lymphatic vessel (Lv). Scale bar for a, c, d, e, f, h, i 
is 2000nm and 5000nm for b,g 
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Fig. 3: Ultrastructural micrograph of seminiferous tubule portion of group H highly active 
antiretroviral therapy ([HAART] only). This group has several ultrastructural abnormalities and 
disorganised germinal cells (a) alteration in the normal progression of cells in the germinal 
epithelium. Round Spermatid (St) and late spermatids (red arrow) appearing in the basal 
compartment. There is also depletion of the spermatogonic cells (b) and (c) showing irregularity in 
the outline of the BM (d) showed increased thickness in BM (Bm) and myoid cell (My), there is 
widening of the internuclear space between Sertoli cells (Se) (e) shows degenerative changes in the 
nuclear membrane (blue arrow) (f), (g) and (h) shows abnormally formed spermatid heads (yellow 
arrow)  and disorganised axonemes in cross section of midpiece (blue star) surrounded by 
abundance of residual cytoplasm (Rc) (i) shows the interstitium with normal Leydig cells having 
slight nuclear indentation. Scale bar for a, d, f, h is 2000nm and for b, c, e, g, i is 5000nm. 
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Fig 4: Ultrastructure of the testes of rats in N40 (Naringenin 40mg/kg) (a) showing normal 
Progression of cells of the spermatogenic series (b)The spermatogonia (Sg) and Sertoli cells 
(Se) are resting on BM, the spermatogonia (Sg), spermatocytes (Sp) have well 
circumscribed nucleus (N) and well defined nuclear membrane (c) The BM demonstrates 
normal thickness and myoid cell with the nucleolus of the Sertoli cell resting on it (d) (e). 
The different stages of development of the spermatids are seen, the round spermatids (St) 
and the late spermatids (LSt) The residual cytoplasm of the late spermatids are present close 
to the lumen with the midpiece (Mp) suspended within (g) The Leydig cells (Ly) are seen in 
the interstitium (h) and (i) shows the Leydig cell (Ly) in the interstitium (In) with abundant 
mitochondria and lipid droplets. Scale bar for a, c, e, f, g, i is 2000nm and b, d, h are 
5000nm. 
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Fig 5: Ultrastructure of the testes of rats in N80 (Naringenin 80mg/kg) (a) showing normal 
Progression of cells of the spermatogenic series (b)The spermatogonia (Sg) and Sertoli cells (Se) are 
resting on BM, the spermatogonia (Sg), and Sertoli cells (Se) have well circumscribed nucleus (Nu) 
and normal internuclear space (c) The BM demonstrates normal thickness and myoid cell (d) is 
showing the basal compartment consisting of the primary spermatocyte (Sp), the Sertoli cell and the 
spermatogonia (e), (f) and (g) presents the ad luminal compartment (ALC) with the cross section of 
the midpiece and flagellum made up of the principal pieces and the end pieces. Also seen is the 
residual cytoplasm (Rc) and vacuoles (v) surrounding the midpiece (g) The Leydig cells (Ly) are 
seen in the interstitium (h) and (i) shows the Leydig cell (Ly) in the interstitium (In) with abundant 
mitochondria, lipid droplets and a blood vessel (Bv) containing red and white blood cells. Scale bar 
for a, b, c, e, f, g, h, i is 2000nm and d is 5000nm. 
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Fig. 6: Ultrastructure of testes of group HN40 (a) Sertoli (Se) and spermatogonic cells (Sg) lined along 
the BM (Bm) (b) and (c) myoid cells of the BM in close relation with the spermatogonic cells (Sg) 
(d) shows slight thickening of the BM (e) and (f) presents primary spermatocytes showing some 
degenerative changes in the nuclear membrane (blue arrow) (g) cross section of the tails of late 
spermatids showing the midpiece (Mp), principal piece and endpiece (Ep), there are a few midpieces 
with disorganised axonemes (blue star) (h) shows abnormal spermatid heads (red star) (i) presents the 
Leydig cells with deep indentations and blood vessels in the iinterstitium. Scale bar for a, b, c, d, e, g, 
h are 2000nm and 5000nm for f, and i. 
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Fig 7: Ultrastructure of testes of group HN40 (a) Normal progression of cells of the spermatogenic 
series (b) & (c) The Sertoli (Se) and Spermatogonic (Sg) cells lie on the BM (Bm) with myoid cells 
(d) The BM has a relatively straight outline with slight thickening (e) Round spermatids (St) 
displays acrosomal cap and occasional degeneration of nuclear membrane (f) Lumen of 
seminiferous tubule containing cross section of tails showing the midpieces (Mp) and the principal 
pieces (Pp) (g) Late spermatids (LSt) in the process of spermiation.  There is some residual 
cytoplasm (Rc) around the midpiece (Mp) (h) presents occasional abnormal forms in the late 
spermatids (red star) (i) Leydig cells (Ly) lie with the interstitium (In). Scale bar for (a), (c), (d), (f), 
(g), (h) is 2000nm and 5000nm for (b), (e), (i). 
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BRIDGING 
BETWEEN CHAPTERS FOUR AND FIVE 
The previous chapter was able to demonstrate the toxic effects of antiretroviral therapy on 
the oxidative status of the testicular tissue and the attendant effects on the ultrastructural of 
the organ particularly as it relates to Sertoli and Leydig cell functions. The palliative role of 
Naringenin was further revealed in the manuscript to further delineate the mechanism of 
injury to the testes. Testosterone biosynthesis begins from the transfer of cholesterol from the 
cytoplasm to the inner mitochondrial membrane by StAR protein (Steroidogenic acute 
regulatory protein), this is followed events under the control of the steroid-synthesizing 
enzymes in testicular Leydig cells including 3 beta-hydroxysteroid dehydrogenases (3β 
HSD). The activity of this steroidogenic enzyme and regulatory protein is critical for normal 
steroidogenesis and the subsequent spermatogenesis.  Having observed changes in the Leydig 
cells, the next chapter clarifies the effects of ARD on the expression of testicular 3β HSD and 
spermatogenesis. 
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BRIDGING 
BETWEEN CHAPTERS FIVE AND SIX 
The findings of earlier chapters have all revealed the beneficial properties of Naringenin, a 
bioactive flavonoid when co-administered with antiretroviral therapy. The next chapter 
summarises the findings and suggested recommendations. 
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6 CHAPTER SIX 
SYNTHESIS, CONCLUSION, RECOMMENDATION 
6.1 Synthesis 
The overall aim of this study is to determine the impacts of the recently approved first line 
antiretroviral therapy for adults FDC, TDF/FTC/EFV on the testes and explore the role of 
Naringenin, a potent antioxidant in alleviating testicular perturbations induced by HAART. 
An analysis of the effects of Naringenin on HAART-induced alteration in semen parameters, 
hormonal changes, oxidative imbalance, histochemical changes, cytoarchitectural changes in 
the testis using histomorphometric indices including volume fraction of seminiferous 
epithelium, tubular lumen, intersitium as well as ultrastructural changes were considered.  As 
noted in the existing body of literature, studies from our laboratory have suggested the 
deleterious effects of ARVs on the testes using the older generation antiretroviral 
combinations.  Azu et al. (2014), described the deleterious histopathological changes in the 
testes; changes observed include tubular atrophy with altered morphometric indices.  Also 
reported were significant decline in sperm motility, decline in epithelial height closely 
mirrored by extensive reticulin framework and positive PAS cells (Ogedengbe et al., 2016, 
Ismail et al., 2017). Even though this study employed the more recent drugs in the HIV 
management guideline that are considered safer, it was shown that they are not completely 
devoid of adverse effects.  Thus corroborating the findings of previous research (Ogedengbe 
et al., 2016, Ismail et al., 2017). Tenofovir, Emtricitabine and Efavirenz (TDF/FTC/EFV) 
combination is the current first line therapy for persons being commenced on HAART. This 
informed the choice of HAART and the duration of treatment in this two-phase study. Despite 
the success in reduction of morbidity and mortality achieved during this HAART era, the 
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population of persons on HAART is increasing. Most of these individuals are in their 
reproductive years and desire their own biological children (Basu, 2007).  Using this 
combination of HAART, there was distortion of the seminiferous tubular epithelium with 
dead immotile multinucleated cells in the lumen. The diameter of the seminiferous tubules 
were also severely decreased. These were observed following both short term (28 days) and 
long term (10 weeks) use of TDF/FTC/EFV combination. The evidence of spermatogonic 
cells without spermatozoa in the lumen of the seminiferous tubules is suggestive of 
unsuccessful spermiation (Beardsley and O'Donnell, 2003). These findings clearly support 
the literature insofar as there is a strong positive link between use of HAART and testicular 
microanatomical changes. An intact seminiferous epithelium and interstitial tissue in the 
testes is required for optimal steroidogenesis and hence spermatogenesis.  
In order to delineate the mechanism of testicular injury, the study investigated the effects of 
HAART on Sperm mitochondrial DNA (mtDNA) and progressive sperm motility. The 
spermatozoa have been shown to contain numerous mitochondria necessary to provide 
energy required for progressive motility (van Leeuwen E, 2008). An increase in the sperm 
DNA tail length observed was suggestive of mtDNA fragmentations. The mitochondria 
powers sperm motility and underlies a successful spermiation. This was reflected in the 
reduction of percentage of progressively motile sperm in the semen analysis. Tenofovir has 
been reported to cause renal proximal tubular ultrastructural defects and depleted mtDNA in 
that specialized tissue (Kohler et al., 2009). White et al (2001), suggested that the proportion 
of patients with mitochondrial DNA (mtDNA) deletions was significantly greater in those 
patients who had taken HAART for more than 12 months compared with those who had taken 
HAART for less than 12 months (White et al., 2001). Some scholars have hinged the decrease 
191 
 
in progressive sperm motility on the relationship between HAART induced toxicity and 
mitochondrial damage (Soriano et al., 2008, Kohler et al., 2009, Patil et al., 2015). 
The deleterious effects were extended to other semen parameters revealing a reduction in 
sperm count as well as an increase in the percentage of sperms with abnormal morphology. 
The sperm count of animals treated with HAART decreased significantly to less than 1% of 
those observed in controls, and the motile sperm cells had comparatively decreased by 70% 
in the HAART-treated group. Similarly, the sperm morphology showed a marked increase in 
abnormalities especially tail abnormalities. This is in tandem with the observations of 
researchers who used a different combination of HAART (Ogedengbe et al., 2017a, 
Ogedengbe et al., 2017b, Ismail et al., 2017, Jegede et al., 2017, Azu et al., 2014b). In 2011, 
Nicopoullos and his colleagues postulated that HAART significantly decreases total sperm 
count, progressive motility, and increases the number of abnormal forms (Nicopoullos et al., 
2011). A clear pointer to the biochemical property of the class of ARV being used and not 
necessarily individual drugs as the culprit in this menace. 
The mechanism by which HAART induces organ injury particularly testicular toxicity may 
likely be due to cascade of events involving the oxidant-antioxidant pathway (Azu et al., 
2014a, Azu, 2012; Olaniyan, 2015). Earlier studies have reported that increased activities of 
reactive oxygen species (ROS) overwhelms tissue`s total antioxidant status leading to 
oxidative stress (Aitken 2011; Aitken, 2008; Aitken, 2007). Oxidative stress leads to 
increased lipid peroxidation indicated by malondialdehyde (MDA) markers, deleterious to 
the unsaturated fatty acid rich membrane of the spermatozoa (Oremosu and Akang, 2015). In 
order to further understand the ongoing events at cellular levels, an analysis of testicular 
antioxidant activity was carried out. HAART was associated with a reduction in the activity 
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of testicular antioxidant enzymes. The activities of glutathione peroxidase decreased while 
that of catalase displayed a marginal decline. Due to the delicate balance in the oxidant-
antioxidant system in the testes and its role in spermatogenesis, an abnormal semen parameter 
is expected. This has been proposed to underlie the mitochondrial DNA fragmentation and 
hence decline in normal process of spermiation.  
Excessive accumulation of free radical production follow a reduced activity of antioxidant 
enzymes. This obstructs the biosynthesis of testosterone essential for the proper functioning 
of the Sertoli-Sertoli tight junction which constitutes part of the blood-testis-barrier, and 
normal spermatogenesis (Aly et al., 2017). A shortage of this steroid hormone will be 
counterproductive on spermatogenesis, which is unlikely to progress beyond diplotene 
spermatocytes stage (Smith et al., 2015, De Gendt et al., 2004, Tsai et al., 2006). The 
implication thereof, corroborates with our previous study which showed that HAART 
decreased sperm count, sperm motility and sperm morphology and increased sperm DNA 
fragmentations. 
Using transmission electron microscopic studies, this study reports alteration of the normal 
ultrastructure of the testes following HAART use. This is evidenced by degeneration of 
nuclear membranes, an altered and disordered cellular progression in the germinal epithelium 
as well as irregular contouring and thickening of the basement membrane. A result of cellular 
infiltration of the basement membrane. This has been shown to be associated with tubular 
degeneration and impedance of metabolic exchange between the germinal epithelium and the 
interstitium (Amat et al., 1985). The impaired metabolic exchange is frequently accompanied 
by subsequent gonadotrophin deficiencies, a typical finding in crypto-orchidism 
(Hadziselimović, 1977, Hadžiselimović, 1982). Similar pathology has been noted in other 
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atrophic testes with a different aetiology (Neaves, 1977). The altered exchange of materials 
within the testicular tissue with further induced basement membrane infiltration and hence a 
continuous cycle of basement membrane thickening.  Also observed is the alteration in the 
normal progression of the cells in the seminiferous germinal epithelium. This was 
demonstrated by the presence of elongating spermatids being retained and resorbed into 
basilar Sertoli cell cytoplasm within the basal compartment. The spermatogonic cells along 
the basement membrane were observed to be scanty following the use of HAART. However 
the Sertoli cells seem unaffected, there was an associated reduction in the population of 
primary spermatocytes. The spermatocytes and round spermatids displayed incomplete 
nuclear membrane. These are indicative of an ongoing degenerative process within the cell. 
The morphological changes described has been associated with impaired Sertoli cell function 
(Vidal and Whitney, 2014). Other studies that described the morphologic changes in the rat 
testes such as spermatid retention and degeneration of cells linked it with decreased 
intratesticular testosterone levels (Beardsley and O'Donnell, 2003, Troiano et al., 1994). Our 
study revealed obstructed spermatogenesis and widening of the interstitium, with fewer 
Leydig cells in HAART treated animals. The implication thus corroborates with our previous 
study which showed that HAART decreased sperm count, sperm motility and sperm 
morphology and increased sperm DNA fragmentations. 
The activity of this steroidogenic enzyme and regulatory protein 3 beta hydroxysteroid 
dehydrogenase (3β HSD) is critical for normal steroidogenesis.  The findings from this study 
clearly demonstrates a reduction in the expression of testicular 3β HSD. Moreover, normal 
steroidogenesis is promoted by the maintenance of normal mitochondrial pH, membrane 
potential and ATP synthesis is necessary for steroidogenesis (Wang et al., 2015, Park et al., 
2014). It is only reasonable to infer that the down regulation of testicular 3β HSD by 
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TDF/FTC/EFV therapy explored the oxidant-antioxidant pathway. These findings are in 
tandem with reports by some scholars who reported that the alteration in mitochondrial 
antioxidants adversely affected 3β HSD expression and Leydig cell steroidogenesis (Jana et 
al., 2010). Thus, a deficiency of this steroid hormone will be deleterious to optimal 
spermatogenesis. 
The effect on male fertility was further revealed by the reduction in the pregnancy rates in 
male rats exposed to fertile females when compared to controls. This is the first study to 
determine the fertility rate in males following long term use of TDF/ETC/EFV using animal 
models. There are still a lot of puzzles to be unravelled concerning mammalian reproduction 
and infertility. In human infertility has been recorded in many cases where both partners are 
normal and healthy. So also, pregnancies have been reported in few cases with abnormal 
semen parameters and hormonal perturbations. The continual search for answers by 
researchers in the different related medical fields is the only hope for success. 
The co-administration of Naringenin proved beneficial. The protective effects of Naringenin 
was observed with respect to semen parameters especially in the short term use of HAART. 
The normal cellular progression was restored and cells of the spermatogenic series were well 
represented however there persist occasional defects in the continuity of the nuclear 
membrane of the cells.  Kwatra et al (2016) revealed that naringin usage, a closely related 
flavonoid ameliorated the oxidative stress, proinflammatory cytokines, mitochondrial 
dysfunction and improved monoamines contents in brain hippocampus of Doxorubicin 
treated rats (Kwatra et al., 2016). Addition of Naringenin to oseltamivir treatment improved 
the neurofunctions of the brain through improving the Y maze task and reductions in the 
pathophysiological effect of oseltamivir. This was attributed to increasing total antioxidant 
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capacity, brain fatty acid binding proteins FABP7 and Ca-ATPase and reducing oxidative 
(Hegazy et al., 2016). In the same study Naringenin was proposed to have reduced total nitric 
oxide, total oxidant capacity and total cytochrome P450 (CYP450) contents (Hegazy et al., 
2016).  
Some studies have proposed an improvement in the antioxidant activity. Supplementation of 
Naringenin and its synthetic derivative enhanced antioxidant enzyme activities of erythrocyte 
and liver in high cholesterol-fed rats by enhancing the antioxidant defence system (Lee et al., 
2002).  In cisplatin-Naringenin combined treated rats, the activities of superoxide dismutase, 
glutathione peroxidase, and catalase were significantly increased (Badary et al., 2005).  
In spite of this deleterious effects of HAART, the Naringenin co-treated animals especially 
at a lower dose (40 mg/kg) had an increased expression of testicular 3β HSD compared to 
those treated with HAART only. Likewise, the histomorphology and morphometry showed 
complete spermatogenesis with a very conspicuous presence of spermatozoa in lumen of the 
seminiferous tubules. During oxidative stress, Naringenin chelates ions and scavenge ROS 
(Jamalan et al., 2016). 5-hydroxy and 4-carbonyl groups in the C-ring of Naringenin play a 
role in ROS scavenging, as well as copper (Cu) and iron (Fe) ions interaction. Naringenin 
also restores mitochondrial membrane potential mitigating mitochondrial dysfunction and 
subsequent apoptotic cascade (Jamalan et al., 2016). This finding confirms the fact that 
antioxidant supplementation may be useful adjuvants in the treatment of HAART-induced 
toxicities (Azu, 2012, Jegede et al., 2017).   
The study proposed a number of mechanisms for the observed protection from Naringenin. 
Naringenin possess chelating properties capable of binding to toxic metal ions to form 
complex structures, which make it easier to eliminate from intracellular or extracellular 
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spaces. Cavia-Saiz et al (2010) also proposed that Naringenin acts as an active chelator of 
metallic ions. The ameliorative effects of Naringenin may also be attributed to its chemical 
structure. The hydroxyl groups present are able to donate electrons and mop up generated 
free radicals from the altered oxidative status thereby restoring the oxidant-antioxidant 
balance in the testes. This provides an insight into the mechanism of gonadotoxic effect of 
antiretroviral therapy.  
Other proposed mechanism not investigated by this study include the oestrogen modulating 
activities and its ability to alter peroxisome proliferator-activated receptor (PPAR) alpha and 
PPAR gamma signalling by enhancing insulin-stimulated tyrosine phosphorylation and 
insulin tissue sensitivity (Kuiper et al., 1998, Kannappan and Anuradha, 2010, Goldwasser 
et al., 2010). Further probe into these properties may expand the present understanding of its 
adjuvant roles. 
6.2 Conclusion  
This study reveals that both the short-term and long-term use of HAART may predispose to 
degeneration of the seminiferous tubules, abnormality of sperm parameters, and increased 
sperm DNA fragmentations. This places PLWHA at an increased risk of infertility. The study 
proposes that TDF/FTC/EFV therapy impacts negatively on male fertility by distorting 
testicular ultrastructure thereby causing Sertoli cell dysfunction and impaired 
spermatogenesis and steroidogenesis which ultimately reduce fertility in the male rats.  A 
balance of the oxidant-antioxidant status of the testes is necessary for optimal 
spermatogenesis. Maintaining this poses a challenge in the presence of antiretroviral therapy. 
This warrants the use of free radical scavenging agents to ensure maintenance of an 
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equilibrium.  Be that as it may, the use of Naringenin promises moderate mitigation of 
HAART-induced perturbations. 
Naringenin’s ability to mitigate HAART (FDC- TDF/FTC, EFV) induced testicular changes 
in the ultrastructural architecture and function of the testes suggests that the observed 
protection was due to its antioxidant, metal chelating and possibly anti-inflammatory 
properties, which could present it as a useful adjuvant in the treatment of HIV patients 
especially those desirous of future fertility.  
 
6.3 Limitations and Recommendations      
 The study utilized healthy animal models to demonstrate effects of HAART on male 
fertility. It will however be more representative of a true life situation if an HIV model 
is used. This may reveal the possible interaction that may influence tissue response to 
injury.  
 The principle of replacement, refinement and reduction is strictly implemented by the 
animal house of the Biomedical Resource Unit (BRU) and the Animal Research 
Ethics committee (AREC) of the University of KwaZulu-Natal. The number of 
animals per group was limited to five. A larger sample size particularly with regards 
to the Fertility index would be more statistical validity. 
 More extensive research on the long-term use and a probe into the afore-discussed 
oxidant– antioxidant mechanism of action of HAART and Naringenin on the male 
fertility axis is encouraged to better understand the activity of HAART on male 
reproductive health.   
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 Safer alternatives to the presently used drug combination in the HAART therapy need 
to be researched and introduced since it is easier to prevent these toxicities than deal 
with its attendant adverse effect. Antioxidant therapy derived from phytonutrient that 
possess anti-inflammatory properties may be introduced into the management of HIV 
at an early stage of the disease to reduce or prevent observed toxicities. 
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Appendix III 
RAT DISSECTION GUIDE 
INTRODUCTION 
Rats are often used in dissection classes because they are readily available and they 
possess the typical mammalian body plan. Most of what you learn on the rat is 
applicable to the anatomy of other mammals, such as humans. 
RAT DISSECTION GUIDE 
EXTERNAL FEATURES 
 
Refer to the drawing below and identify the indicated structure on the rat prior to skinning. 
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Vibrissae - also referred to as the "whiskers". They have a sensory function that allows the 
animal to 
judge the size of an opening that it is about to pass through. 
 
Nares - the nares (plural) or naris (singular) are the external openings into the nasal cavity. 
 
Female urogenital structures 
Urethral orifice - is the opening into the urethra (part of the urinary system). 
Vaginal orifice - is the opening into the vagina (part of the reproductive system). 
 
Male urogenital structures 
Penis - is hidden on the male rat beneath a fold of skin (the foreskin or prepuce). 
Scrotum - is a pouch that contains the testes (see the drawing below) 
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Skinning the rat 
Make a midventral incision as illustrated on the drawing above. Use your probe, scissors 
and finger to free the skin from the underlying tissue. Follow the basic cut pattern 
illustrated on the first page of this handout. 
f 
I 
I 
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You should encounter two brownish muscles attached to the skin (the cutaneous maximus 
in the trunk area, and the platysma in the neck area). You will probably have to cut these 
muscles close to the skin before the skin can be removed. 
 
MUSCULAR SYSTEM 
The diagram below illustrates the muscles of the ventral surface of the rat. Be able to 
identify those listed. Use the photographs on the following pages and your lab atlas to assist 
you. 
 
 
 
 
214 
 
 
Head and Throat muscles 
Digastric - this V shaped muscle follows the lower jaw line. It functions to open the mouth. 
 
Mylohyoid - runs at right angles to the longitudinal axis. You may have to gently raise up 
the edge of the digastric muscle on each side of the jaw in order to see this muscle. It 
functions to raise the floor of the mouth. 
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Sternohyoid - runs parallel to the longitudinal axis on either side of the midline. It functions 
to pull the hyoid towards the sternum. 
 
Sternomastoid - runs diagonally from the sternum to a point behind the ear. It functions to 
rotate the head to one side (when one contracts), or rotates the head down (when both 
contract). 
 
Masseter - this is the "cheek" muscle. It functions in mastication (chewing). 
 
Chest and Front leg (medial) muscles 
Pectoralis Major - the large triangular muscle covering the upper thorax. It functions to pull 
the arm towards the chest. 
 
Pectoralis Minor - part of this muscle runs beneath the Pectoralis Major. It function is the 
same as the Pectoralis Major. 
 
Biceps Brachii - the large muscle located on inside of the upper arm. It functions to flex 
(bend) the lower arm. 
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Epitrochlearis - this is a flat, thin muscle on the medial surface of the upper arm. It 
functions to extend the lower arm. 
 
Flexors - the collection of small muscles on the medial surface of the lower arm. They 
function to flex the wrist and hand. 
 
Shoulder and Lateral (outside) Muscles of the Front Leg 
Be able to identify the muscles illustrated on the drawing on the next page. 
Clavotrapezius - one of a group of three muscles that help to stabilize the scapula. Its 
function is to pull the clavicle forward. 
 
Acromiotrapezius - pulls the scapula forward. Spinotrapezius - pulls the scapula downward. 
Latissimus dorsi - pulls the arm downward. 
Serratus ventralis - is made up of fingerlike projections of muscle running between the 
armpit and the ribs. Its function is to depress the scapula. 
 
Cleidobrachialis - runs between the clavicle and the humerus. Its function is to pull the arm 
forward. 
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Acromiodeltoid - Runs between the outer clavicle and the scapula. Pulls the upper arm 
away from the ribs. 
 
Spinodeltoid - runs between the scapular spine and the upper arm. Pulls the scapula away 
from the ribs. 
 
Triceps brachii - this is a muscle with three heads. It runs between the scapula and humerus 
and the ulna. Its function is to extend the lower arm. 
 
Brachialis - runs next to the Biceps Brachii. Its function is to flex the lower arm. 
 
Extensors - a group of small muscles on the lateral side of the lower arm. They extend the 
wrist and hand. 
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Deep Muscles of the Shoulder 
Identify the deep muscles illustrated on the drawing above. 
Rhomboideus - runs between the dorsal border of the scapula and vertebral column. Its 
function is to pull the scapula in and forward. 
 
Supraspinatus - covers the lateral side of the scapula, above the scapular spine and attaches 
to the upper arm. Its function is to pull the upper arm forward. 
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Infraspinatus - covers the lateral side of the scapula, below the scapular spine and attaches 
to the upper arm. Its functions is the rotate the upper arm outwardly. 
 
Teres Major - runs along the outer edge of the scapula to attach to the upper arm. Its 
function is to rotate the humerus laterally. 
 
Hip and Lateral Muscles of the Hind Leg 
Identify the muscles illustrated on the drawing below. 
 
Gluteus Superficialis - covers a large portion of the anterior hip. Its function is to pull the 
thigh outward. 
 
Biceps Femoris - located posterior to the Gluteus. Its function is to pull the upper leg 
outward and flex the lower leg. 
 
Semitendinosus - it is located on the posterior margin of the leg and is partly hidden by the 
Biceps Femoris. Its function is to flex the lower leg. 
 
Gastrocnemius - the major "calf" muscle on the posterior surface of the lower hind leg. Its 
function is to extend the foot. 
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Soleus - located under the Gastrocnemius. Its function is to extend the foot. 
 
Tibialis Anterior - located on the anterior surface of the lower hind leg. Its functions is to 
flex the foot. 
 
Hip and Medial Muscles of the Hind Leg 
Be able to identify the following muscles illustrated on the drawing on page 3 of this 
handout. 
 
Gracilis - a flat muscle on the caudal (near the tail) portion of the inner thigh. Its function is 
to pull the thigh inward. 
 
Rectus femoris - located on the anterior (front) surface of the thigh. Its function is to extend 
the lower hind leg. 
 
Vastus medialis - runs parallel to the Rectus femoris on the caudal side. Its function is to 
extend the lower hind leg. 
 
Adductor Magnus and Brevis - runs parallel to and beneath the Gracilis. Its function is 
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to pull the thigh towards the body. 
 
Adductor Longus - runs parallel to and beneath the Vastus Medialis. Its function is to pull 
the thigh towards the body. 
 
Pectineus - located next to the femoral vein. Its function is to pull the thigh towards the 
body. 
 
Abdominal Muscles 
Be able to identify the following muscles illustrated on the drawing on page 3 of this 
handout. 
 
External Oblique - covers most of the ventral and lateral abdomen. Its function to compress 
and hold the internal organs in place. 
 
Rectus Abdominis - runs parallel to the longitudinal axis of the body on either side of the 
linea alba. Its function is to compress and hold the internal organs. 
 
Throat and Oral Cavity 
222 
 
Be able to identify the structures illustrated on the drawing below. The structures indicated 
are components of a variety of organ system. 
 
Parotid Gland - the major salivary gland. Its function is to secrete saliva containing starch 
digesting enzymes. 
 
Parotid duct - empties saliva from the Parotid Gland into the oral cavity. 
 
Mandibular gland - a salivary gland that secretes a thick mucous. 
 
Sublingual gland - a small salivary gland that empties into the oral cavity behind the lower 
incisors. 
 
Lymph Nodes - part of the immune system. 
 
Lacrimal Gland - secretes lacrimal fluid (tears) to lubricate the eye. 
 
The Abdominal Cavity and the Digestive System 
Be able to identify the structures illustrated on the drawing below. 
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Dissection - use scissors to make a midventral cut up the entire length of the abdominal 
cavity. 
When you reach the diaphragm (a broad sheet of muscle that separates the thorax from the 
abdomen) make lateral cuts along the lower border of the rib cage. 
 
Parietal Peritoneum - a very thin and shiny membrane that lines the inside of the abdominal 
wall. 
 
Visceral Peritoneum - a very thin and shiny membrane that covers the internal organs of the 
abdominal cavity. 
 
Mesenteries - folds of the Visceral Peritoneum that attach the small intestine and colon to 
the posterior abdominal wall. 
 
Liver - is the large brown organ taking up most of the anterior portion of the cavity. I 
consists of four lobes. Its function is to manufacture bile, selectively remove and 
reintroduce nutrients into the blood, remove toxins, and manufacture needed proteins and 
carbohydrates. 
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Gall Bladder - the rat does not have a gall bladder. 
 
Stomach - a curved bag-like organ right below the diaphragm. Its function is to 
mechanically grind up the food and start the digestion process. 
 
Esophagus - muscular tube that passes through the diaphragm to empty food into the 
stomach. 
 
Small Intestine - composed of three major parts. The stomach empties its contents into the 
first section of the intestine called the Duodemum. The Ileum is the terminal section of the 
small intestine that connects with the cecum. The middle section (between the duodenum 
and ileum) is the Jejunum. The small intestine is where most digestion and ingestion occurs. 
 
Large Intestine (Colon) - is shorter and wider than the small intestine. The ileum of the 
small intestine empties into the first section of the colon, the Cecum. The Vermiform 
Appendix is a blind-ended sac attached to the cecum. The appendix functions as a 
lymphatic organ in immunity and often becomes infected in humans. 
 
Rectum - the terminal portion of the colon leading to the anus. 
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Spleen - is located to the left of the stomach at the end of the pancreas. It functions in 
immunity. 
 
Pancreas - has a glandular lobular appearance and is attached to the duodenum. It has both a 
digestive function (it secretes enzymes) and a hormonal function. 
 
Respiratory System 
Be able to identify the structures illustrated on the drawing below. 
 
Trachea - air tube with conspicuous rings. Gently move the contents of the thorax around 
until it can be found. 
 
Bronchus - the trachea divides into a left and right bronchus. Gently move the contents of 
the thorax around until they can be found. Like the trachea they have conspicuous rings. 
 
Lungs - appear spongy and on either side of the heart. The right lung on the rat has four 
lobes and the left lung has three. Each lung is covered by a thin layer of tissue called the 
Visceral Pleura. The inside of the thoracic wall is covered by a similar layer called the 
Parietal Pleura. 
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Diaphragm - is a thin sheet of muscle separating the abdomen from the thorax. When 
contracted it draws air into the lungs. 
 
The Circulatory System 
Be able to identify any of the blood vessels illustrated on the drawing above and below that 
you can find without cutting any internal organs out of your specimen. 
 
Heart - sits in the space between the left and right lungs. Portions of the right and left atria 
can be seen as dark flaps on top of the heart. The two anterior vessels and one posterior 
vessel entering the right atrium are the Vena Cavae that return unoxygenated blood to the 
heart. 
 
Pulmonary Veins can be seen leaving each lung and entering the Left Atrium. 
The Ventricles (right and left) can not be differentiated without opening the heart. A 
Pulmonary Artery can be seen exiting the right ventricle and passing under the Aorta. 
 
Pericardium - is the tough fibrous sack surrounding the heart for protection. 
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MAJOR ARTERIES 
 
Aorta - is the major artery shown exiting the top of the heart and forming an arch that bends 
to the left. It empties the left ventricle and supplies oxygenated blood to the entire body. 
 
Brachiocephalic Artery - is the first artery to branch off of the Aorta. It supplies 
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blood to the head and right arm. This artery splits to from the Right Subclavian Artery that 
takes blood to the right arm, and the Right Carotid Artery that takes blood to the head. 
 
Left Common Carotid Artery - is the second artery to branch off of the Aorta. It supplies 
blood to the head. 
 
Left Subclavian Artery - is the third artery to branch off of the Aorta. It supplies blood to 
the left arm. 
 
Common Iliac Artery - divides to form the Internal Iliac Artery (supplying various organs 
in the pelvic area) and the External Iliac Artery (passing to the leg). 
 
Femoral Artery - is an extension of the External Iliac Artery located on the medial surface 
of the thigh. 
 
MAJOR VEINS 
 
Subclavian Vein - as it returns blood from the arm in connects with the Lateral Thoracic 
Vein, External Iliac Vein, and, Internal Iliac Vein to form the Anterior Vena Cava. 
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Anterior Vena Cava - enters the right atrium on the dorsal side of the heart. 
 
External Iliac Vein - runs parallel to the External Iliac Artery. 
 
Internal Iliac Vein - runs parallel to the Internal Iliac Artery. 
 
Posterior Vena Cava - formed when the right and left Common Iliac Veins unite. It empties 
into the right Atrium. The Renal Artery and Iliolumbar Artery drains into it. 
 
Hepatic Portal Vein - takes blood from the digestive organs to the liver. Should be injected 
with yellow latex. 
 
FEMALE URINARY AND REPRODUCTIVE STRUCTURES 
Be able to identify the structures illustrated on the drawing of the Female Urogenital 
System below. 
 
Kidney - can be found close to the dorsal wall of the abdomen surrounded by fat. 
 
Ureter - is a whitish tube extending from each kidney and running to the Urinary Bladder 
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where urine is stored. 
 
Ovary - is a small nodular gland often found buried in fat near each kidney. 
231 
 
 
Uterus - in female rats the uterus is split into two Uterine Horns. The distal 
end of each horn is located close to each ovary. 
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